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Transcription factors (TFs) regulate the expression of tissue specific genes. In the 
Drosophila embryonic salivary gland (SG), four of these transcription factors include: CrebA, 
fork head (fkh), Sage, and sensless (sens). CrebA and its Creb3-like homologs are known for their 
regulation of secretory capacity.  fkh is a regulator of SG morphogenesis and, with Sage and sens, 
controls SG survival. With the exception of Sage, all of these TFs are expressed in multiple 
tissues. To determine the SG-specific direct targets of these TFs, all four were tagged with GFP in 
preparation for Chromatin Immunoprecipitation and sequencing (ChIP-seq) in which GFP would 
be pulled down. The GFP-tagged forms were expressed using two drivers that have the SG in 
common, so by studying the intersection of these two datasets, SG-specific binding can be 
inferred. As controls, wild-type embryonic chromatin is immunoprecipitated with either CrebA or 
Sage antisera. For CrebA, which is ubiquitously expressed, this potentially permits us to 
distinguish tissue-specific targets of CrebA from CrebA targets bound in all tissues. Because Sage 
is SG specific, a comparison of the GFP datasets and the wild-type Sage pull down dataset 
controls for the accuracy ofgood the Sage-GFP dataset. All of the GFP tagged TFs are fully 
functional, and to date, we have obtained the results for CrebA binding. For the Fkh, Sage, and 
Sens data, we have sent the prepared chromatin to our collaborators at University of Minnesota, 
Duluth. The CrebA ChIP-seq datasets revealed that CrebA binds to open chromatin containing 
consensus CrebA binding sites; that the subset of genes that CrebA regulates are involved in 
secretion, including Xbp1, TSN, and tbc1; and that loss of CrebA and/or the binding sites leads to 
misregulation of Xbp1 and TSN. The highly conserved gene, tbc1 is known to be involved in the 
trans Golgi network from mammalian studies and we find that it is localized to the trans most 
portion of the TGN in Drosophila. Loss of tbc1 leads to apical membrane defects and secretion 
defects in the SG and cuticle secretion defects. This predicted Rab-GAP co-localizes with several 
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Tubular organs are responsible for many vital processes, including the exchange of gases 
(vertebrate lungs, insect trachea), absorption and secretion (kidneys, small intestine, pancreas, 
salivary glands), and circulation of nutrients and immune cells (blood vessels) (Andrew and 
Ewald, 2010).  Some organs, such as the central nervous system, initially start development as a 
tube, but their further development obscures this early architecture. Many diseases are directly 
related to issues in tube formation and/or maintenance, including spina bifida, polycystic kidney 
disease, and aortic aneurysms.  Thus, understanding the cellular and molecular mechanisms 
underlying the formation, homeostasis and function of tubular organs is vital. Direct study of 
mammalian tubular organs is complicated by the intricacy of the organs, redundant gene function, 
and in utero development. On the other hand, the salivary gland (SG) of Drosophila 
melanogaster is an ideal model system for the study of epithelial tube biology because it forms a 
simple, unbranched tubular epithelium in a matter of only a few hours. Embryos are clear and 
immuno-stained SGs are easily visible by light and confocal microscopy. An armamentarium of 
genetic tools exists in Drosophila for eliminating gene function, either ubiquitously or in a tissue-
specific manner, or for overexpressing various forms of different proteins in specific cell types 
(Kanca et al., 2017).  Finally, genetic redundancy is much less of a factor in flies than in 
mammals (Yamamoto et al., 2014; Chung et al., 2014).  
Salivary gland specification is evident early in development (embryonic stage 10) as two 
SG placodes (plates of columnar epithelial cells) on the ventral surface of the embryo in the 
posterior head region begin to express SG-specific proteins (Chung et al., 2014).  Each placode 
contains around 140 cells and, after specification, there is no cell division or cell death as this 
tissue develops.  Once specified, SG cells change shape, rearrange and invaginate dorsally into 
the embryo to form simple, unbranched epithelial tubes (embryonic stages 11 and 12) (Chung et 
al., 2017; Roper, 2012).  As the cells of the developing SG tubes contact the layer of muscle 
surrounding the developing gut, known as the visceral mesoderm, the tube turns and migrates 
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posteriorly along this structure to its final position, parallel to the long axis of the embryo (stages 
13 - 15) (Bradley and Andrew, 2001).  SGs invaginate and migrate as fully polarized, intact 
epithelial tubes, although the SG cells undergo considerable rearrangement to transform the SG 
primordia into internalized, elongated tubular structures (Sanchez-Corrales et al., 2018).   
The embryonic SG placode is specified by the combined activities of three transcription 
factors (TFs): Sex combs reduced (Scr), Extradenticle (Exd), and Homothorax (Hth) (Figure 1) 
(Henderson and Andrew, 2000).  These TFs function as a complex to activate the expression of 
several other TFs involved in the survival, morphogenesis, and function of the SG: fork head 
(fkh), sage, CrebA, and huckebein (hkb).  Fkh and Sage, in turn, activate the expression of the TF 
senseless (sens) (Fox et al., 2013).  Shortly after expression of Fkh, Sage, CrebA, and Hkb are 
activated and as SG morphogenesis begins, expression of Scr, Exd, and Hth disappears.  Fkh, 
Sage and CrebA continue to be expressed in the SG throughout the lifetime of the organ, with 
Fkh maintaining its own expression and expression of CrebA, Sage and Sens. Hkb, on the other 
hand, is only transiently expressed in the early SG.  
Figure 1: TF Pathway of Drosophila Embryonic Salivary Gland.  Modified from Fox et 
al 2013 
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Loss of fkh, sage, or sens leads to loss of the embryonic SG through apoptotic cell death 
(Chandrasekaran and Beckendorf, 2003; Myat and Andrew, 2000a).  SG apoptosis can be rescued 
by the presence of a deficiency that removes the apoptotic regulators that are activated in the SG 
when these proteins are missing (Myat and Andrew, 2000a; Fox et al., 2013) or overexpression of 
the baculovirus P35 anti-apoptotic protein (Fox et al., 2013).  Sens expression in the SG requires 
both fkh and sage and the ectopic activation of sens requires both Fkh and Sage (Fox et al., 2013). 
All of the genes encoding SG specific cargo and the enzymes that modify that cargo require Fkh 
and Sage, and often Sens, for full levels of SG expression, and the ectopic expression of Fkh and 
Sage is sufficient to activate expression of these SG-specific genes in ectopic sites in the embryos 
(Fox et al., 2013). Stainings of 3rd instar larval SG polytene chromosomes with antisera to Fkh, 
Sage and Sens reveal significant overlap in the binding sites for all three proteins. Binding sites 
for these three TFs do not, for the most part, overlap with the binding sites observed for CrebA 
(Maruyama et al., 2011;Fox et al., 2013).  This led to the hypothesis that Fkh, Sage, and Sens act 
in a complex to regulate both SG survival and expression of SG specific gene products. CrebA is 
proposed to function in parallel to increase secretory capacity (Fox et al., 2010).  
When the cell death of fkh mutant SGs is rescued, the SGs have severe morphological 
defects: the SGs completely fail to undergo the cell shape changes associated with early SG 
development and remain as two placodes of cells on the embryo surface (Weigel et al., 1989).  
Rescuing the cell death phenotype of Sage mutants results in relatively normal SGs, with a 
significant reduction in lumenal volume, consistent with the decreases in SG cargo gene 
expression that are also observed.  
Unlike the other four TFs, Hkb, a Sp1/Egr-like TF, is only transiently expressed in the 
SG (Myat and Andrew, 2002). SG expression of hkb mRNA normally ceases during invagination. 
Loss of hkb leads to a failure in apical expansion due to defects in targeting of apical vesicles, 
resulting in SGs that are fully internalized but not elongated (Myat and Andrew, 2000b). Not 
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surprisingly, persistent overexpression of Hkb leads to overly expanded apical lumens with fully 
elongated SG tubes (Myat and Andrew, 2002).   
CrebA is unique among the early expressed TFs because its loss results in only mild 
morphological SG defects (Abrams and Andrew, 2005).  Rather than playing a role in SG 
morphogenesis, CrebA is critical for the function of the SG.  Specifically, CrebA increases 
secretory capacity in the SG by coordinate upregulation of expression of Secretory Pathway 
Component Genes (SPCGs) (Abrams and Andrew, 2005; Fox et al., 2010). This was initially 
shown by in situs comparing expression of 34 known SPCGs in wild-type and CrebA mutant 
embryos and by subsequent microarray analyses comparing mRNA levels in wild-type and CrebA 
mutant embryos.  The microarray analysis revealed that CrebA not only upregulates SPCGs but 
also expression of mRNAs encoding SG cargo. It is unclear if the upregulation of SG cargo by 
CrebA is direct or indirect but it is likely that CrebA could directly activate most SPCGs. Fox et 
al (2010) showed that SG expression of several (4/5) tested SPCGs required the presence of 
consensus CrebA binding sites (Fox et al., 2010).  A universal role for the CrebA family in the 
regulation of SPCGs is supported by experiments showing that expression of CrebA or the 
activated forms of any of the five human homologs of CrebA (known as the Creb3-like proteins) 
is sufficient to induce ectopic expression of all tested SPCGs in Drosophila embryos (Fox et al., 
2010; Barbosa et al., 2013).  In further support of CrebA/Creb3L proteins functioning to boost 
secretory capacity is the observation that murine loss of the two most closely related CrebA 
homologs, Creb3L1/OASIS and Creb3L2/BBF7H2, have osteogenesis and chondrogenesis 
defects, respectively, and both proteins have been implicated in upregulating expression of a 
subset of COPII proteins (Keller et al, 2017; Saito et al 2009).    
Sage is the only known TF expressed solely in the SG (Abrams et al., 2006).  Fkh and 
CrebA are expressed in multiple tissues beside the SG, including in the proventriculus, hindgut, 
epidermis and central nervous system (Andrew et al., 1997; Weigel et al., 1989).  Sens is also 
expressed in the peripheral nervous system, whereas hkb is also expressed in a subset of cells in 
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the central nervous system (Fox et al., 2013; Myat and Andrew, 2000b).  This widespread 
expression of SG TFs presents a challenge for assaying tissue-specific binding of these TFs by 
ChIP-Seq.  To get around the issue of the broad expression domains of most of these proteins, we 
tagged each of the TFs with GFP to perform ChIP-seq, pulling down on SG expressed TF-GFP.  
CrebA, Fkh, Sage, and Sens tagged with GFP were expressed in the SG using two different 
drivers.  Neither driver is SG specific, but the only tissue in which both are expressed is the SG. 
Thus, we can identify SG specific binding events by determining which peaks overlap in 
independent experiments using the two drivers. The ChIP-seq and analysis of CrebA is complete 
(discussed in Chapter 1), whereas we are awaiting the ChIP-seq data from our collaborators for 
Fkh, Sage, and Sens (discussed in Chapter 3).   
In Chapter 1, we find that CrebA is binding open chromatin in the SG and that binding is 
driven by the presence of known consensus CrebA binding motifs determined by in vitro assays 
(Abrams and Andrew, 2005; Nitta et al., 2015; Noyes et al., 2008).  We show that CrebA binds 
almost all SPCGs but only a small subset of SG cargo genes.  In addition to SPCGs, CrebA also 
activates expression of other regulators of gene expression, Including Xbp1 and TSN, a 
transcription factor and potential regulator of mRNA stability, respectively.  CrebA also regulates 
a novel SPCG, tbc1, which has been shown to be involved in endosome to Golgi trafficking in 
mammalian systems (Shin et al., 2017).  Mutation of CrebA binding sites in Xbp1 or TSN, led to 
cuticle secretion defects.  Loss of TSN or tbc1 caused similar phenotypes.  In the SG, mutations in 
all three genes resulted in secretion defects. Altogether, this suggests that CrebA not only 
regulates effectors of secretory capacity (such as tbc1) but also regulators (such as Xbp1 and 
TSN). 
Further analysis of tbc1, discussed in Chapter 2, shows that loss of tbc1 leads to apical 
membrane irregularities.  GFP-tagged Tbc1 does not localize to secretory vesicles or the ER, but 
does partially colocalize with the recycling endosome marker Rab11 near the apical surface.  
Endogenous Tbc1 also partially colocalizes with the trans-Golgi marker Golgin-245 but not the 
   
7 
 
cis-Golgi marker GM130.  Tbc1 is predicted to be a Rab-GAP (GTPase Activating Protein). To 
determine any potential interactors, Tbc1 and candidate YFP-Rabs were overexpressed 
mosaically in the SG.  Tbc1 partially colocalized with Rab-X1, -5, -8, -9, and -10. In an effort to 
determine if Tbc1 might have an effect on the levels of Rab proteins, we tested Rab5 and Rab11 
and found that neither loss nor overexpression of Tbc1 had an overt effect on Rab5 or Rab11 
accumulation levels.  
In Chapter 3, the generation and testing of the GFP constructs for Fkh, Sage, and Sens are 
discussed. It was found that ubiquitous expression of each tagged protein phenocopies the 
activities observed with ubiquitous expression of the corresponding untagged forms. Expression 
of the GFP tagged TFs also rescued the SG cell death phenotypes associated with loss of each of 
the TFs. Finally, the Sage antiserum that will be used as a control (pulling down Sage in wild type 
embryos) fully recognizes Sage-GFP.  Altogether, these experiments suggest that the GFP 
constructs are fully functional. Chromatin for these experiments has been prepared and shipped to 
our collaborators at the University of Minnesota, Duluth. We excitedly await the results from this 
analysis.  
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CrebA directly regulates both regulators and effectors of secretory capacity 
 
  




CrebA/Creb3L-like proteins coordinately regulate expression of the protein machinery of 
secretory organelles and boost expression of secretory cargo. To gain insight into the mechanism 
by which these bZip transcription factors regulate target gene expression in a tissue-specific 
manner, we developed an assay to identify CrebA DNA binding sites in the developing 
embryonic salivary gland (SG) of Drosophila. We demonstrate that CrebA binding is linked to 
open chromatin and the presence of consensus binding sites previously discovered through in 
vitro assays. We show that CrebA functions as a transcriptional activator and that it is necessary 
and/or sufficient for the expression of ~80% of the tested SG expressed genes to which CrebA 
binds in vivo. We demonstrate the importance of the consensus sites in CrebA transcriptional 
activation by mutating the consensus sites in the context of the endogenous enhancers of two of 
the newly discovered CrebA transcriptional targets, Xbp1 and Tudor-SN (TSN). Finally, we 
describe secretory roles for three newly discovered direct CrebA target genes, two regulators – 
Xbp1 and TSN – and one downstream secretory effector –Tbc1. The mammalian orthologues of 
both CrebA and Xbp1 have been implicated in the unfolded protein response. Our findings 
suggest that the ER stress induced by drugs and excess unfolded proteins activates endogenous 
pathways that normally function to accommodate the increased secretory load of professional 
secretory cells. Altogether, these findings emphasize the role of the CrebA/Creb3L-like proteins 
in the direct regulation of secretory capacity and suggest that many/most of the additional direct 
targets of CrebA identified in this study function in secretion. 
  




 Organs are uniquely specialized for their functions. The lungs, pancreas, and liver have 
not only unique architectures but also unique gene expression profiles. For example, the lungs 
have elaborate tubular arborizations that provide large surface areas for gas exchange. The 
specialized type II cells of the lungs produce and secrete high levels of surfactant proteins, which 
serve to protect the lung tissue from alveolar collapse, reduce surface tension, and increase 
compliance (Mendelson, 2000). The pancreas comprises large secretory acinar cells linked by 
small ductal tubes to either the main or accessory pancreatic ducts. The pancreas is functionally 
divided into both an endocrine and exocrine pancreas, which produce and secrete high levels of 
either hormones (insulin and glucagon) or digestive enzyme precursors (amylase, lipase, and 
proteases such as trypsinogen), respectively (Jennings et al., 2015). The liver has an unusual 
architecture, which allows close contact between liver cells and the arteries and veins that carry 
the blood coming from the digestive tract to be appropriately altered before its passage to the rest 
of the body (Ober and Lemaigre, 2018). Genes encoding xenobiotic receptors and detoxifying 
enzymes are upregulated in the liver because of its role in removing toxins from the bloodstream 
(Larigot et al., 2018). The liver is important in the processing and storage of nutrients, and thus 
also encodes the enzymes involved in, for example, the conversion of glycogen to glucose for 
release into the blood as a quick energy source.  
Organ specific gene expression is controlled by a unique combination of transcription 
factors (TFs). In the lung, surfactant expression is controlled by Thyroid transcription factor 1 
(TTF-1, also known as Nkx2.1) and Hepatic nuclear factor 3 (HNF-3) (Mendelson, 2000; Yang et 
al., 2018). The pancreatic program of gene expression is activated by Pancreatic and duodenal 
homeobox 1 (PDX1) and Pancreas transcription factor 1A (PTF1A). Working with another 
transcription factor – the Gli Family Zinc Finger 3 (GLIS3), Pdx1 also specifies the endocrine 
progenitors and beta cell precursors in the pancreas (ZeRuth et al., 2013). The MyoD family of 
transcription factors controls expression of hundreds of muscle specific genes, including not only 
   
14 
 
the proteins of the contractile unit of muscle, known as the sarcomere, but also regulators of 
mitochondria biogenesis such as PCG-1β, since muscle cells have very high energy requirements 
(Shintaku et al., 2016).  
Many specialized organs have exaggerated needs for what are considered housekeeping 
functions, such as the increases in mitochondrial biogenesis observed in muscles. Professional 
secretory cells, like those found in the pancreas, salivary and mammary glands, must increase 
secretory capacity to produce the high levels of digestive enzymes, hormones, saliva and milk 
required for organismal homeostasis and/or offspring survival. The CrebA/Creb3-like family of 
TFs has been shown to expand secretory capacity (Abrams and Andrew, 2005; Barbosa et al., 
2013; Fox et al., 2010). Within Drosophila, where the general role of CrebA/Creb3-like family 
members was first revealed, loss of the single family member CrebA results in significant 
decreases in the expression of secretory pathway component genes (SPCGs) in tissues where 
these components must be upregulated for the organ to function properly, such as the salivary 
gland (SG) and epidermis. CrebA larvae are unable to hatch from the eggshell and have little or 
no cuticle compared to wild type (Abrams and Andrew, 2005; Fox et al., 2010). This is due to the 
lack of secretion of cuticle components by the epidermis. The upregulation of the SPCGs, which 
is highest in the SG where CrebA expression is highest and where its function was first 
characterized, has been shown to be direct for a small subset of SPCGs (Fox et al., 2010). Mice 
null for two CrebA orthologues, Creb3L1 [aka OASIS] and Creb3L2 [aka BBF2H7], have defects 
in osteogenesis and chondrogenesis, respectively (Saito, 2014). Both phenotypes are consistent 
with the Creb3L1 and Creb3L2 proteins functioning to increase secretion in the respective cell 
types (osteoblasts/osteocytes and chondroblasts/chondrocytes). Additionally, members of a 
family carrying a point mutation in the Creb3L1 gene develop osteogenesis imperfecta, also 
known as brittle bone disease (Keller et al., 2017). Ectopic expression of CrebA, as well as 
ectopic expression of the active form of any of the five human Creb3-like transcription factors, in 
the Drosophila embryo leads to upregulation of all SPCGs that have been tested to date (Barbosa 
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et al., 2013; Fox et al., 2010). Altogether, the phenotypes associated with loss of CrebA and its 
closest human orthologues, as well as the activity of the protein in Drosophila embryos, support a 
universal role for CrebA/Creb3-like proteins in the upregulation of secretory machinery.  
Interestingly, whereas CrebA regulates expression of the protein components of the 
secretory organelles, including the endoplasmic reticulum (ER), Golgi, transport and secretory 
vesicles, it does not upregulate lipid biogenesis (Fox et al., 2010). As a consequence, when CrebA 
function is lost, there is an increase in plasma membrane accumulation at the septate junctions 
(the invertebrate equivalent to tight junctions), which presumably represents the excess lipid that 
would normally populate the ER, Golgi and secretory vesicle membranes (Fox and Andrew, 
2015).  
Microarray studies in developing embryos comparing CrebA null mRNA levels to WT 
levels revealed not only decreases in SPCG transcripts, but also decreases in transcript levels for 
genes encoding secretory cargo (Fox et al., 2010). It is unclear whether regulation of cargo genes 
by CrebA is direct or indirect since CrebA is required to achieve full wild-type levels of 
expression of Sage, an SG-specific bHLH transcription factor that works with the Drosophila 
FoxA orthologue, known as Fkh, to active SG expression of secreted cargo.  
To find additional CrebA targets and to distinguish between direct and indirect 
transcriptional regulation, chromatin precipitation with a CrebA antibody followed by sequencing 
of the DNA that precipitates with the CrebA protein (ChIP-Seq) would be a good approach. Since 
CrebA is expressed in multiple embryonic tissues and since the embryonic SG is too small to 
surgically isolate, it is difficult to use this approach to identify SG-specific binding of CrebA in 
the embryo. To circumnavigate these challenges, we use a variation on ChIP-Seq that allows us to 
identify SG-specific binding events. Specifically, we perform ChIP-seq using GFP antibodies on 
chromatin isolated from embryos expressing a GFP-tagged and functional form of CrebA in the 
SG. For quality control, we compare the binding events identified using this strategy to those 
observed with chromatin isolated from whole embryos and immuno-precipitated with CrebA 
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antiserum. Our experiments reveal that CrebA binds a large portion of the genome (~1%) and that 
CrebA is binding to open chromatin. Our analysis of the CrebA-bound DNA suggests that 
binding is driven by the occurrence of consensus CrebA binding motifs within this open 
chromatin. We demonstrate that CrebA is necessary and/or sufficient for wild-type levels of SG 
expression for a large subset of SG genes bound by CrebA but not previously known to be CrebA 
targets. Three of the genes for which CrebA function is both necessary and sufficient for their 
expression are Xbp1, TSN, and tbc1, which we implicate in secretory function. Using 
CRISPR/Cas9-directed mutagenesis, we show that two key consensus CrebA binding sites in the 
Xbp1 gene and one in the TSN gene are necessary for their CrebA-dependent expression and their 
secretory function in two different tissues. 
  




Approach to identifying tissue-specific CrebA binding sites  
CrebA is expressed in multiple embryonic tissues, including the salivary gland (SG), 
proventriculus, trachea, and epidermis (Fig 2A). Thus, to identify in vivo CrebA binding sites 
specifically in the SG, we used the Gal4/UAS system to express a CrebA transgene tagged at its 
C-terminus with GFP (CrebA-GFP) for ChIP-Seq (chromatin immunoprecipitation followed by 
DNA sequencing) using a well-characterized GFP antibody that has been used extensively for 
ChIP-Seq studies of Drosophila transcription factors (Kittler et al., 2013; Kudron et al., 2018; 
Loganathan et al., 2016; Negre et al., 2011). Two Gal4 drivers were used, fkh-Gal4 and sage-
Gal4; both drive UAS-transgene expression in multiple tissues, but have only SG expression in 
common (Fig 2B-C).  
 To test the functionality of the UAS-CrebA-GFP transgene, we expressed both untagged 
UAS-CrebA and UAS-CrebA-GFP in embryonic stripes using the en-Gal4 driver and examined 
expression of Spase12, a known downstream target of CrebA (Fig 3A,B; (Fox et al., 2010). 
Expression of both transgenes resulted in ectopic expression of Spase12 mRNA in stripes (Fig 
3B), with levels roughly corresponding to the levels of detectable CrebA protein (Fig 3A). We 
also expressed both UAS-CrebA and UAS-CrebA-GFP in alternating segments using prd-Gal4 in 
the background of both wild-type and CrebA null animals, and examined the resulting first instar 
larval cuticles. Consistent with the expression domain of the prd-Gal4 line (Fig 3C,D), expression 
of both CrebA constructs resulted in changes in dorsal hair morphology in approximately every 
other segment in otherwise WT larvae (Fig 3E-G”). Loss of CrebA lead to a loss of cuticular 
structures on all larval surfaces, with barely visible denticles, as previously reported (Fig 3H; 
Abrams and Andrew, 2005; Fox et al., 2010). Expression of either untagged or GFP-tagged 
CrebA in a CrebA mutant rescued the cuticle defects in the alternating segments where   prd-Gal4   
is expressed   (Fig 3I-J). Finally, we immunostained SG polytene chromosomes expressing the 
UAS-CrebA-GFP   transgene   under   the   control   of   fkh-Gal4   with   CrebA   antiserum,   which  
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Figure 2: Experimental approach to identify CrebA binding sites in whole embryos and 
salivary glands (SG). (A) CrebA expression was detected with the rabbit polyclonal CrebA 
antiserum used for whole embryo ChIP-Seq, shown at embryonic stages 10, 14, and 16 (ventral 
views). Black arrowhead: SG; white arrowhead: proventriculus; black arrows: epidermis; white 
arrows: trachea. (B-C) GFP expression was observed in the SG with UAS-CrebA-GFP expressed 
under the control of either fkh-Gal4 (B) or sage-Gal4 (C) at embryonic stages 10, 14, and 16 
(ventral views st10 and st16, lateral views st14). Black arrowheads: SG. (D) The cartoon outlines 
the scheme to identify CrebA binding sites in whole embryos and in SGs using ChIP-Seq. (E) 
Salivary gland polytene chromosomes from WT larvae (top) and larvae expressing CrebA-GFP 
under the control of fkh-Gal4 (bottom). Note that the bands on wild-type chromosomes stained 
with CrebA antiserum made in either rat or rabbit completely overlap. Similarly, the bands that 
stain with CrebA (rat) antiserum completely overlap the bands that stain with GFP antiserum 
(rabbit).   
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Figure 3: GFP-tagged CrebA tagged is fully functional. (A) WT embryo (left), and embryos 
expressing either untagged CrebA (middle) or GFP-tagged CrebA (right) under the control of en-
Gal4 and stained with CrebA antiserum. Black arrows: ectopic CrebA expression in segmental 
stripes; black arrowheads: endogenous CrebA expression in the SG; white arrowheads: 
endogenous CrebA expression in amnioserosal cells. (B) in situ hybridizations with a probe to a 
known target of CrebA, spase12. Shown are a WT embryo (left), and embryos expressing either 
untagged CrebA (middle) or GFP-tagged CrebA (right) under the control of en-Gal4. Black 
arrows: ectopic spase12 expression in segmental stripes; black arrowheads: endogenous spase12 
expression in the SG. (C) Cartoon of prd-Gal4 expression pattern in larvae. (D) CrebA protein in 
embryos expressing UAS-CrebA-GFP under control of prd-Gal4. (E-J) Cuticle preps of 1st instar 
larvae. (E) Ventral view of a WT larva (E) and larvae expressing CrebA transgenes under the 
control of prd-Gal4 (F,G). (E’–G’) Lateral view of a WT larva (E’) and larvae expressing CrebA 
transgenes under the control of prd-Gal4 (F’,G’). (E” – G”) Higher magnification phase images 
of lateral views of a WT larva (E”) and larvae expressing CrebA transgenes under the control of 
prd-Gal4 (F”,G”). Arrowheads indicate regions with thicker hair structures on the dorsal surface 
in cells expressing either untagged or tagged CrebA. (H) CrebA mutant larval cuticle. (I) Region-
specific rescue of CrebA mutant by untagged CrebA driven by prd-Gal4 in alternating segments. 
(J) Region-specific rescue of CrebA mutant by GFP-tagged CrebA driven by prd-Gal4 in 
alternating segments.  
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should detect both endogenous and expressed GFP-tagged CrebA, and anti-GFP, which should 
detect only the expressed GFP-tagged CrebA. Antisera recognizing both proteins completely 
colocalized (Fig. 2E). Altogether, these findings indicate that the GFP-tagged CrebA protein is 
functionally equivalent to the untagged protein both in its ability to activate target gene 
expression in new domains, in its ability to rescue loss of CrebA phenotypes, and in its ability to 
bind SG chromatin.  
 
Identification of SG-specific CrebA binding sites 
In vivo CrebA binding sites were identified by comparing independent biological replicates of all 
three experiments to input DNA controls (from non-immunoprecipitated chromatin) (Fig. 2D). A 
large number of binding peaks, called by the MACS program (Zhang et al., 2008), were observed 
in all three experiments (Fig. 5A): 14,012 peaks were observed with WT chromatin pulled down 
with αCrebA (referred to as the WT-CrebA set); 6,457 peaks were observed with fkh-Gal4::UAS-
CrebA-GFP chromatin precipitated with αGFP (referred to as the fkh-GFP set); and 7,903 peaks 
were observed with sage-Gal4::UAS-CrebA-GFP chromatin immunoprecipitated with αGFP 
(referred to as the sage-GFP set). We used the Intersect function through the Galaxy platform 
(usegalaxy.org) to identify approximately 4000 sites common to all three experiments, with the 
exact number depending on the order of the comparisons (Fig 4); 3884 binding sites were 
identified when the comparisons began with the WT-CrebA set and either of the GFP sets and 
4303 binding sites were identified when the comparisons were done with the GFP sets first (Fig 
5A, Fig 6A,A’).  
Between 80 and 88% of the binding intervals common to the sage-GFP and fkh-GFP sets 
were also observed in the WT-CrebA set, indicating that the approach to find SG-specific CrebA 
binding sites worked well. Between 28% and 31% of sites in the WT-CrebA set were also in the 
SG-specific set, indicating that CrebA does not bind the same sequences in all tissues and that 
sites  bound  in  the  SG  represent  a  substantial  part  of  the  total. The  intervals  shared  between 
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Figure 4: Diagram of how each dataset was generated by using Galaxy intersection 
function. 
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the fkh-GFP and sage-GFP sets but not found in the WT-CrebA set suggest that either the 
increased level of CrebA expression is driving increased occupancy or that the GFP pull-downs 
are more sensitive. For simplicity, we will refer to the sets of genes pulled down by all three 
experiments as the SG-specific sets. SG-specific set 1 comprises the 3884 sites obtained in the 
intersection starting with the WT-CrebA data (Fig. 5A) and SG-specific set 2 comprises the 4303 
sites obtained in the intersection starting with the fkh-GFP and sage-GFP data (Fig 6A). 
We also compared the three ChIP-Seq datasets using a variation of the Galaxy program 
that identifies the exact interval of base pair overlap in the data from all three experiments. This 
analysis identified the same 5115 sequences regardless of the order of comparisons (Fig 6A’). 
Notably, 90.8% of the sequences that overlap between the fkh-GFP and sage-GFP sets were also 
present in the WT-CrebA set, again indicating that the experimental approach worked. We refer 
to this set of sequences as SG-specific set 3.  
To gain insight into what drives CrebA SG chromatin binding, we ran each of the SG-
specific sets through the SepPos motif analysis program in the Cistrome/Galaxy Platform that 
searches for sequences matching the motifs of known transcription factors (Liu et al., 2011). The 
number one sequence cluster identified from the analysis of all three SG-specific sets 
corresponded to the consensus binding sites for Creb3L1 and Creb3, two known mammalian 
orthologues to Drosophila CrebA (Fig. 5B, 6B,B’). This cluster also includes Xbp1, a 
transcription factor that plays a major role in the unfolded protein response (UPR) and that binds 
to approximately the same consensus sequence. The second sequence cluster discovered for SG-
specific set 1 was Creb3L2 (Fig. 5B), another CrebA mammalian orthologue, which is also found 
as cluster 4 in SG-specific sets 2 and 3 (Fig 6B,B’). Otherwise, the remaining top clusters for SG-
specific set 1 include a motif for FoxN1 (Fig. 5B) and a variety of different transcription factors 
(not shown), whereas motifs for Helix-Loop-Helix (HLH) family members were prominent in the 
analysis of SG-specific sets 2 and 3 (Fig. 6B.B’). The differences in motifs identified among the 
three sets likely reflect the biases in the overlap analysis that produced them – SG-specific set 1 is 
   
25 
 
Figure 5: CrebA ChIP-seq binding and motif enrichment for Set 1. (A) Venn diagram of 
ChIP-seq peaks and overlaps. (B) SepPos analysis of motifs enriched in the intersection of all 
three datasets identified consensus binding sites for several known mammalian transcription 
factors. The motif logo for the transcription factors in the first cluster is shown below the cluster 
table. (C) Percentage of binding peaks with at least one identifiable CrebA consensus binding 
site, based on FIMO analysis of all CrebA motifs either individually or combined. The CrebA 
consensus binding sites, obtained from previously published studies are shown. (D) Centrimo 
analysis of 250bp on either side of peak summits from the intersection of all three datasets; 
summits were determined using the fkh-Gal4 driven dataset. All three of the consensus motifs 
analyzed show enrichment around the summit. (E) The top 10 categories of GO terms based on 
DAVID analysis of called targets that have peaks in all three datasets. 
  




   
27 
 
Figure 6. Parallel analyses of ChIP-seq binding site data for SG sets 2 and 3. (A,A’) 
Proportional Venn Diagrams showing the overlap in binding sites from all three experiments. (B, 
B’) Identification of top motifs for known mammalian transcription factors enriched in the 
intersection of all three datasets. (C,C’) Centrimo analysis of 250bp on either side of peak 
summits from the intersection of all three datasets; summits were determined using the fkh-Gal4 
driven dataset. All three of the consensus motifs analyzed show enrichment around the summit. 
(D,D’) The top 10 categories of GO terms based on DAVID analysis of called targets that have 
peaks in all three datasets. 
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biased toward CrebA binding in whole embryos and could reflect binding sites for the range of 
tissue-specific factors that may cooperate with CrebA for gene regulation and/or differences in 
chromatin accessibility in the different tissues. SG-specific sets 2 and 3 are biased toward CrebA 
binding in the SG and could reflect SG-specific transcription factors and/or chromatin 
accessibility. Notably, an HLH transcription factor known as Sage, which is expressed to very 
high levels in embryonic SGs, has previously been implicated in controlling SG-specific gene 
expression (Fox et al., 2013).  
We used FIMO (Bailey et al., 2009) to explore the extent to which in vitro CrebA 
consensus motifs (Abrams and Andrew, 2005; Fox et al., 2010; Nitta et al., 2015; Noyes et al., 
2008) can account for in vivo CrebA SG binding. Notably, 94.5% of the bound sequences in SG-
specific set 1 contain at least one CrebA consensus-binding site (p-value = 0.001) (Fig. 5C). 
Bound sequences in SG-specific sets 2 and 3 contained at least one identifiable CrebA consensus 
sequence 85.8% and 74.5% of the time, respectively. The somewhat smaller number in SG-
specific set 3 may reflect how this set was generated, where only the exact (partial) sequences 
found in all three experiments were included.  
Centrimo analysis was done to determine where in the binding peaks the most 
represented CrebA consensus sites are located (Bailey et al., 2009). This analysis of 500 nt 
regions revealed that the consensus sites tend to be close to the summit of each peak (Fig. 5D; 
Fig. 6C,C’). Thus, CrebA consensus sites, determined through in vitro DNA binding studies, are 
driving the in vivo binding of CrebA as revealed by ChIP seq.  
To identify the genes associated with the SG-specific sets of binding sites, we assigned 
each binding site to a target gene based on the nearest protein coding gene transcription start site 
(TSS) (Slattery et al., 2011). There are 2406 associated protein coding genes that have peaks in 
SG-specific set 1, 2397 in SG-specific set 2, and 2339 in set 3; 2236 protein coding genes 
(87.1%) are shared among all three sets. DAVID gene ontology analysis was done to learn what 
classes of genes CrebA binds in the SG (Huang da et al., 2009a; Huang da et al., 2009b). 
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Regardless of which SG-specific set was used for this analysis, similar types of functional 
clusters were revealed (Fig. 5E; Suppl. Fig. 6D,D’). Most notably, transcription factors and other 
nucleic acid binding proteins emerge in the top categories with all searches. Other prominent 
clusters were PH-domain containing proteins, septate junctions (SJs) and GTPases. These 
findings were surprising, since previous expression studies indicate that CrebA primarily 
regulates secretory pathway component genes and secretory cargo (Fox et al., 2010). This 
outcome suggests that CrebA binding per se does not indicate gene regulation and may instead be 
simply a consequence of chromatin accessibility combined with the presence of one or more 
CrebA consensus-binding site. 
 
SG binding sites and links to gene regulation  
To begin to explore how CrebA binding is linked to CrebA-dependent gene expression, 
we compared genes identified by the CrebA ChIP-Seq experiments to those whose expression is 
known to change in CrebA mutants based on previous microarray analyses (Fox et al., 2010). 
This comparison was done for each SG-specific class; in the best scenario, represented by the SG-
specific set 1 data, 15.2% of genes that go up and 27.7% of genes that go down in CrebA mutants 
relative to WT are bound by CrebA in the SG (Fig 7A). To ask if increased site occupancy 
correlates with gene regulation, we binned binding sites according to peak height and then plotted 
peak height against the microarray genes known to go up or down in CrebA mutants (Fig 7B). 
Consistent with CrebA binding to a higher percentage of genes that go down in CrebA mutants, 
we see a trend of increased binding and increased percentage of genes that require CrebA for their 
expression. No such trend was observed with genes whose expression went up in the absence of 
CrebA, suggesting that CrebA primarily functions as a transcriptional activator. DAVID analysis 
of the categories of genes that are both bound by CrebA and whose expression goes down in 
CrebA mutants relative to WT based on the microarray studies revealed Secretory Pathway 
Component Genes (SPCGs) in the top four categories (Fig. 7C).  
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Figure 7. CrebA ChIP-Seq binding and CrebA regulation. (A) Proportional Venn diagram of 
overlap in target genes bound by CrebA in all three experiments and genes that go significantly 
up or down in microarray experiments comparing RNA from WT embryos and embryos null for 
CrebA. (B) Percentage of CrebA-dependent genes identified in microarray studies plotted relative 
to the strength of binding based ChIP-Seq analysis. (C) The top five categories of GO terms 
based on DAVID analysis of the overlap of called targets from CrebA binding from ChIP-Seq 
and genes whose expression goes down in CrebA mutants based on microarray studies. (D) 
Overlap in called targets from CrebA binding from ChIP-Seq and genes identified by BDGP as 
being expressed in the embryonic SG. (E, E’) Super-resolution images of SG polytene 
chromosomes stained with CrebA antiserum (red) and signal quantification reveal that CrebA 
binds uncondensed chromatin, which does not stain intensely with DAPI (blue). 
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 To test the idea that CrebA binding is linked to permissive chromatin, we first asked what 
percentage of genes expressed in the embryonic SG are bound by CrebA, since the chromatin 
surrounding these genes should be open in the SG during at least some embryonic stages. Of the 
427 genes identified as SG-expressed by the Berkeley Drosophila Genomic Project (BDGP), 
CrebA bound 179 (42%) (Fig. 7D); this finding suggests that CrebA binding is linked to active 
chromatin in the SGs. Open chromatin in any cell type is estimated to be around 20% of the 
Drosophila genome (Milon et al., 2014). 
 To ask more directly if CrebA binds open versus condensed chromatin in SG cells, we 
stained third instar larval SG polytene chromosomes with CrebA and DAPI and imaged using 
super-resolution microscopy. We found that CrebA binding in the SG is to regions of open 
chromatin, i.e. regions of low intensity DAPI staining (Fig. 7E,E’). Since between 74.5 and 
94.5% percent of sites bound in the embryonic SGs contain at least one CrebA consensus site, 
these findings indicate that CrebA binding occurs in open chromatin that contains at least one of 
the consensus sites previously defined in published in vitro binding studies. 
 
CrebA activates expression of its direct SG targets in situ 
 To explore the relationship between CrebA SG binding and CrebA gene regulation, we 
did whole mount in situ hybridizations with probes specific to 33 SG-expressed genes (BDGP) in 
WT embryos, CrebA null embryos, and embryos expressing either GFP-tagged or untagged 
CrebA in en-Gal4 driven stripes (Table 1). The 33 SG genes included eight that did not show 
CrebA binding, three that were bound in the CrebA-GFP (SG) experiments only, and 22 that were 
bound by CrebA in all three sets of ChIP-Seq experiments. The 33 genes included nine that 
encode transcription factors (Table 1, green shading), between 11-13 that encode predicted 
secretory pathway component genes (SPCGs; Table 1, blue shading), and between 11-13 that 
encode a variety of other types of proteins.  
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Table 1: Testing of genes for CrebA regulation. 
Microarray data from Fox et al 2010; only fold changes with p-value of 0.05 or less shown. *Only with Fkh and Sage driven; †Upstream of 
isoform expressed in embryo 
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Myc FBgn0262656 LD32539 No n.s. No No Transcription Factor
Aatf FBgn0031851 RE30678 No -1.30 Yes No Transcription Factor
CG5728 FBgn0039182 LD41803 No n.s. No No Alternative Splicing Regulator
qsm FBgn0028622 GH08941 No n.s. No No Circadian Rythm, GPI Anchored
Tsp96F FBgn0027865 LD19727 No n.s. No No Tetraspanin
Hayan FBgn0030925 GH17483 No n.s. Yes No Serine protease, Innate Immune Response
Eip55E FBgn0000566 LD22255 No -1.47 Yes No Glutathione Biosynthetic Process
PH4alphaSG1 FBgn0051014 IP03659 No -1.54 Yes No Prolyl-4-Hydroxylation (SPCG), SG-specific
eyg FBgn0000625 AT09010 Yes* -1.35 No No Transcription Factor
sage FBgn0037672 RE59356 Yes* -1.96 Yes No Transcription Factor, SG-specific
CG13159 FBgn0033721 RE25177 Yes* n.s. Yes No Secreted protein, SG-specific
fkh FBgn0000659 RE03865 Yes n.s. No No Transcription Factor
sens FBgn0002573 IP01345 Yes n.s. No No Transcription Factor
rib FBgn0003254 LD16058 Yes n.s. No No Transcription Factor
bowl FBgn0004893 LD15350 Yes n.s. No No Transcription Factor
Xbp1 FBgn0021872 GH09250 Yes n.s. Yes Yes Transcription factor
Tudor-SN FBgn0035121 LD20211 Yes -1.93 Yes Yes RNA-induced silencing
roq FBgn0036621 LD12033 Yes -1.32 Yes Yes RNA Binding Factor (Zinc Finger, Ring-type)
eIF3j FBgn0027619 GH12681 Yes n.s. Yes Yes Translation Initiation Factor
Mvl FBgn0011672 LD24465 Yes -1.37 Yes No Metal ion transporter
mnd FBgn0002778 LD25378 Yes n.s. Yes No Amino Acid/Polyamine (leucine) Transporter
GILT1 FBgn0038149 LD47508 Yes n.s. Yes No Disulfide oxido-reductase, lysosomal (SPCG?)
Papss FBgn0020389 LD25351 Yes n.s. No No Sulfate Adenylyl transferase, SG and epidermis (SPCG?)
CG7872 FBgn0030658 LD24870 Yes -1.81 Yes Yes HSP70, ER-Resident (SPCG)
sel FBgn0263260 GH10427 Yes -2.87 Yes Yes Saposin-like, ER-Resident (SPCG)
wbl FBgn0004003 IP02648 Yes n.s. No Yes Protein Folding, ER-Resident (SPCG)
Ufc1 FBgn0034061 LD28985 Yes n.s. Yes Yes Ufmylation Transferase Activity, ER stress response (SPCG)
Der-1 FBgn0267972 GH08782 Yes n.s. No Yes Ubiquitin-Dependent ERAD Pathway (SPCG)
CG5021 FBgn0035944 RE32705 Yes -1.68 Yes Yes Intergral Membrane, Golgi-Resident (SPCG)
CG8230 FBgn0027607 GH02536 Yes -1.52 Yes Yes Dymeclin Family, Golgi-Resident (SPCG)
lqfR FBgn0261279 GH02671 Yes n.s. Yes Yes Epsin-Like domain, Golgi-Resident (SPCG)
tbc1 FBgn0031304 AT03044 Yes -1.23 Yes Yes Rab-GAP, Endosomal to Golgi trafficking, (SPCG)
Osbp FBgn0020626 LD31802 Yes n.s. Yes Yes Oxysterol-Binding (SPCG)































We verified SG expression for all 33 genes and found that for ten of the genes, CrebA 
was neither necessary nor sufficient for their SG expression (Table 1, Fig. 8). These ten genes 
include four for which there was no CrebA binding and six for which binding was detected in all 
three ChIP experiments. Notably, more than half of the genes that were completely unaffected by 
loss or overexpression of CrebA encode transcription factors, the class of genes most highly 
represented in the DAVID analysis of ChIP-Seq bound genes (Fig. 5E).  
CrebA was necessary for full SG expression of nine of the 33 genes we tested but was not 
sufficient, based on the absence of striped expression when CrebA expression was driven in 
ectopic stripes. This class included two additional transcription factors genes, Aatf and sage. 
Notably, CrebA was both necessary and sufficient for expression of almost all known SPCGs. 
Four additional genes, not previously known as SPCGs, were similarly affected by loss and 
misexpression of CrebA: a transcription factor gene – Xbp1, two genes encoding proteins known 
to associate with RNA – Tudor-SN (TSN) and Roquin, and a gene encoding a translation initiation 
factor – EIF3j. For all but one of the genes for which previous microarray studies (of whole 
embryos) had indicated significant decreases in expression in CrebA mutants, decreases were also 
observed in the in situ analyses (Table 1). Importantly, the expression patterns observed with all 
of the genes affected by either CrebA loss and/or overexpression indicate that CrebA functions as 
a transcriptional activator. The failure to observe changes in gene expression patterns in all genes 
bound by CrebA when CrebA function is missing or when CrebA is mis-expressed indicates that 
CrebA binding does not always indicate CrebA regulation. Finding genes that are not bound by 
CrebA based on the ChIP-Seq analysis but whose expression nonetheless changes with CrebA 
loss, suggests that CrebA can also indirectly regulate SG gene expression, perhaps through other 
CrebA-dependent transcription factors. 
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Figure 8: Subset of in situ hybridization of genes from Table 1.Arrowhead: SG; Arrow: RNA 
detected in stripes of cells expressing UAS-CrebA and/or UAS-CrebA-GFP under the control of 
en-Gal4. All genes are expressed or upregulated in the SG. There is no overt change in qsm and 
wbl expression in CrebA¯ embryos; wbl is ectopically expressed in en stripes when CrebA is 
(both untagged and GFP tagged).  qsm and CG13159 do not have ectopic en stripe expression, 
CG13159 is down regulated in the CrebA¯ embryos CG7872, roq, and tbc1 are downregulated in 








CrebA binding and CrebA regulation requires the CrebA consensus sites 
Our next experiments explored the requirements for the consensus CrebA binding motifs for 
regulation of two of the newly identified genes whose expression is fully responsive to changes in 
CrebA, Xbp1 and Tudor-SN (See Table 1). Using CRISPR/Cas9-mediated recombination, we 
mutated the central four nucleotides of both consensus CrebA binding motifs centered in the 
region of the Xbp1 gene that was pulled down in the ChIP-Seq experiments. We used a similar 
approach to mutate two CrebA binding motifs centered in the region of the TSN gene that was 
pulled down in the ChIP-Seq experiments, but succeeded in mutating only one of the two 
consensus sites. The CrebA consensus binding sites map within the 5’ UTR of Xbp1 and within 
the first intron of TSN (Fig. 9). We refer to the CrebA motif mutant alleles as Xbp1CMM and 
TSNCMM. The Xbp1CMM and TSNCMM alleles were balanced and crossed into the appropriate genetic 
backgrounds. Xbp1 mRNA expression in WT embryos and in Xbp1CMM homozygous embryos 
was compared. We also examined expression of Xbp1 from both alleles in embryos expressing 
UAS-CrebA-GFP under the control of en-Gal4. With the WT versions of Xbp1, we observed 
Xbp1 mRNA expression in the developing SGs of WT embryos as well as in ectopic stripes in 
embryos expressing CrebA-GFP under the control of en-Gal4. Xbp1CMM resulted in a loss of SG 
Xbp1 staining and no ectopic stripes of Xbp1 expression in embryos expressing CrebA-GFP in 
stripes (Fig. 10). Similar experiments are in progress with. Future studies will include using these 
binding site mutant lines for ChIP-qPCR with the CrebA antiserum to compare CrebA binding 
between the WT alleles and CMM alleles of both genes. These experiments will provide a 
measure of how much the presence of consensus CrebA binding motifs contributes to binding and 
will allow us to correlate CrebA binding and CrebA regulation. 
 
Xbp1, TSN and Tbc1 are required for SG secretory function  
 The role of Xbp1, TSN, and Tbc1 in SG secretion is unknown. Xbp1 has been 
shown  to  be  involved  in  the  unfolded  protein  response  (UPR).  A  physiological  role  for  this  
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Figure 9: ChIP-seq peaks for Xbp1, TSN, and tbc1. CrebA( blue) is pulldown in wild type 
using CrebA antisera. Arrows indicate location of CrebA binding sites. Xbp1 has two but they are 
40bp apart. Filled arrows are those we successfully mutated and the empty arrowhead is the one 
that was not mutated.   









Figure 10: Xbp1 expression requires CrebA binding sites. Arrowhead: SG. Arrows: arrows 
indicate RNA detected in stripes of cells expressing UAS-CrebA-GFP under the control of en-
Gal4. 
  
   
42 
 
protein is less well understood, but it stands to reason that in a dedicated secretory tissue like the 
SG, there would be need for upregulation of the genes found in UPR. Indeed, since proteolytic 
cleavage and activation of the mammalian Creb3-like proteins also occurs during UPR, many 
considered these proteins to be UPR-specific at least until their loss-of-function phenotypes were 
revealed (Murakami et al., 2009; Saito et al., 2009). TSN has been linked to cell cycle 
progression, where it is thought to partner with E2F-1 to drive the transition from G1 to S phase 
(Su et al., 2015). More recent work shows that it is the TSN degradation of miRNAs that 
promotes cell cycle progression (Elbarbary et al., 2017). More consistent with a potential link 
between TSN and CrebA function is the demonstration that, in Arabidopsis, TSN binds to and 
stabilizes stress-responsive mRNAs that encode secreted proteins (dit Frey et al., 2010) However, 
TSN has also been linked to increases in milk secretion through its proposed transcriptional 
activity in the nucleus (Ao et al., 2015). Thus, to learn how and where TSN functions, we 
generated null mutations by homologous recombination and we made antiserum that detects the 
endogenous protein (Fig. 11). Our immuno-staining reveals that TSN localizes to the ER (Fig. 
12), a prime location to regulate secretion and/or secretory capacity. Recent characterization of 
the mammalian homolog of Tbc1, Tbc1d23, reveals a role for this protein in linking endocytic 
vesicles to the trans Golgi membrane through its binding to either of two trans Golgi proteins and 
the WAVE complex (Shin et al., 2017). Thus, Tbc-1 could also be required for normal secretory 
function in the SG. Thus, we generated a null allele of tbc1 by homologous recombination (Fig. 
13) and we generated antiserum to the C-terminal half of the protein (see Chapter 3 for details on 
the Tbc1 antiserum). Co-staining with antibodies to a cis Golgi marker (GM130) and a trans 
Golgi marker (Golgin-245) revealed that endogenous Tbc1 made “twin spots” with GM130 and 
partially co-localized with Golgin-245 (Fig. 14). We frequently observed staining where GM130 
punctae would be next to Golgin-245 punctae that, in turn, would either overlap with or be next to 
Tbc1 punctae, suggesting that Tbc1 localizes to the trans most portion of the TGN. We also 
observed Tbc1 staining in vesicles near the apical surface that overlapped staining with the apical  
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Figure 11. TSN Knockout generation. A) Genomic location of TSN. The deficiency BSC125 indicated. 
Small arrows indicate direction of transcription. The region removed in the knockout is indicated. TSN KO 
F and R primers were used with pw 25-2 and -3, respectively, to confirm the knockout. The thick black line 
represents the homologous regions used in the knockout procedure. B) PCR of wild type and the TSN 
knockout line. Primers used are those indicated in A. C) In situ stains of TSN and lacZ mRNA in 
heterozygous and homozygous TSN knockout siblings. Green arrows indicate LacZ expression from the 
balancer chromosome; white arrow indicates the salivary gland. TSN mRNA is absent when there is no 










Figure 12. TSN antibody reveals that endogenous TSN and GFP-TSN localize to the ER. A) 
fkh-Gal4 driver embryos stained for TSN (A; red) and the ER marker SG2 (A’; green) and 
merged with DAPI staining (A”; blue). B) fkh-gal4 driven UAS-GFP-TSN stained for TSN (B; 
red), and GFP (B’; green) and merged with DAPI staining (B”; blue). C) fkh-gal4 driven UAS-









Figure 13: Tbc1 Knockout construct. A) Genomic location of Tbc1. The deficiency Exel6004, 
used in later studies, is indicated. Small arrows indicate direction of transcription. The region 
removed in the knockout is indicated. Tbc1KO F and R primers were used with pw 25-2 and -3, 
respectively, to confirm the knockout. The thick black line represents the homologous regions 
used in the knockout procedure. Primers for constructing the knockout homologous regions are 
indicated. B) PCR of two Tbc1 knockout lines, 178 and 305. 178 was used for all the experiments 
throughout the rest of this work. The negative control is one of the lines that is transgenic for the 
knockout construct, and maps to a different chromosome. Primers used are those indicated in A. 
Arrow is expected band for the 5’ end, arrowhead is expected band for the 3’ end. Asterisks 
indicate bands found in the negative control. C) In situ stains of tbc1 and lacZ mRNA in 
heterozygous and homozygous tbc1 knockout siblings. Green arrows indicate LacZ expression 
from the balancer chromosome; Black arrow indicates the salivary gland. tbc1 mRNA is absent 








Figure 14: Localization of Tbc1 to the trans most part of the TGN. Tbc1 (Green), Golgin-245 
(Red) and GM130 (Blue) staining of a WT SG. Boxes mark the higher resolution images. Green 
arrows: Tbc1; Red arrows: Golgin-245; Blue arrows: GM130; Orange arrows: Overlapped Tbc1 








recycling endosome marker Rab11 (van IJzendoorn, 2006). 
To determine if Xbp1, TSN, and tbc1 effect SG secretion, we stained homozygous mutant 
embryos with a polyclonal antibody generated to the nuclear En protein, EnP1,but that also has 
off-target staining in the SG lumen and SG secretory vesicles (Myat and Andrew, 2002). By stage 
16 of embryogenesis, wild-type embryos have a full lumen with little to no vesicular staining in 
the cells (Fig 15A; Fig 16). CrebA null mutant embryos have very thin, sometimes crooked, 
lumenal SG staining domains with no detectable cellular staining (Fig 15B; Fig 16). Embryos 
homozygous for the Xbp1CMM allele, have SGs with very diffuse cellular and lumenal staining 
(Fig 15C; Fig 16). We also often observe samples where the luminal content appears to have 
pulled away from the apical membranes. We compared SGs from homozygous tbc1Null embryos 
from heterozygous mothers to SGs from homozygous tbc1Null mutants whose mothers were also 
homozygous for tbc1Null. tbc1Null maternal/zygotic and tbc1Null zygotic embryos showed an 
increase in light and dark cellular staining (Fig 15D,E; Fig 16), with the maternal/zygotic mutants 
having a slightly stronger, albeit not significant, phenotype. The presence of cellular staining 
suggests that the EnP1-positive lumenal contents are not being trafficked to the cell surface and 
secreted as efficiently as in wild type SGs.  
The SG secretory phenotypes associated with complete loss of TSN as well as with the 
TSNCMM mutants are currently being examined. 
 
Xbp1, TSN and Tbc1 also have a role in cuticle secretion  
It was previously shown that regulators and effectors of secretion lead to deformation or 
loss of cuticle (Fox and Andrew, 2015). For example, both CrebA null mutants and embryos 
homozygous for mutations in genes encoding the protein components of the secretory machinery 
have defects in the cuticle secreted by epithelial cells (Abrams and Andrew, 2005). The 
phenotypes include “ghost-like” cuticles with little to no denticles and hairs, very light, 




Figure 15. Staining of SG lumen. A-H) Represented stainings using an en polyclonal which also stains the SG lumen. A) Wild type, B) CrebA 
null, C) Xbp1CMM, D) Tbc1Null Maternal/Zygotic loss, E) Tbc1Null Zygotic loss. Insets are magnifications of SG. SGs outlined with dashed lines. 
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Figure 16: Quantification of SG defects. A) Quantification of the number of embryos with at least 
one SG with cellular staining and whether the cellular staining was light or dark. B) Quantification of SGs 
based on if they had diffuse staining, the lumen had pulled away, and/or no staining.  
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the end of the trachea, which is filled with fine cuticular threads). To determine if Xbp1, TSN, and 
tbc1 effect secretion, cuticle preparations were made with the CrebA binding site mutants of 
Xbp1 and TSN as well as knock-out mutations of TSN and tbc1. As shown previously, CrebA 
mutants have very little cuticle (a “ghost-like” appearance) and no obvious mouthparts or 
denticles (Fig. 17B). Both TSN knock out larvae and TSNCMM larvae have ghost-like cuticles quite 
similar to those observed in CrebA mutants (Fig. 17C,D). We also observe a high frequency of U-
shaped embryos, where the posterior end is folded back over the more anterior part of the larva 
(Fig. 17C,D). Xbp1 binding site mutants and tbc1 knockout mutants have more subtle defects 
with mouthparts that are shorter and heads that are thinner than in wild type (Fig. 17E-G). Both 
sets of homozygous mutants had a significant increase in the observed cuticle defects. As the 
mouthparts form from secreted cuticle, the defects suggest that both Xbp1 and tbc1 function in the 
epidermal secretion of larval cuticle, although their contributions to the formation of the cuticle is 
not as critical as the contributions from CrebA and TSN.  
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Figure 17. Cuticle preparations of candidates show a range of secretion defects. A-G) 
Representitive cuticle preps. A) Wild type-Lateral View, B) CrebA null C) TSNNull D) TSNCMM, 
E) Wild Type-Ventral View, F) Xbp1CMM, and G) Tbc1Null Maternal/Zygotic loss. Arrowhead 
outline: mouthparts. White arrowhead: U: shaped bend. Scale bar: 100μm. 
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Figure 18: Quantification of Cuticle Defects of Xbp1CMM and tbc1Null. *: p-value=0.02. **: p-
value=0.002. ***: p-value=1.4*10-24.  




Using a fully functional CrebA tagged with GFP (Fig. 3), we performed ChIP-seq to 
reveal the SG-specific binding of CrebA. To this end, we utilized two drivers that only had the 
SG in common and studied the binding peaks that overlapped both datasets. In conjunction, we 
performed ChIP-seq on wild-type embryos using CrebA antisera (Fig. 2). By comparing all three 
datasets, we determined that SG binding represents a large portion of the total CrebA binding and 
that CrebA exhibits tissue-specific binding (Fig. 5,6). Analysis of the motifs present in the bound 
DNA revealed enrichment for the consensus binding sites for the mammalian Creb3-like and 
Drosophila CrebA that had been determined from in vitro studies. The mammalian Xbp1 
consensus-binding site, which is similar to that of the Creb3-like/CrebA proteins, is also enriched. 
CrebA consensus binding motifs are enriched around the binding peak summits from the ChIP-
Seq analysis, suggesting that the in vitro CrebA binding motifs also function in vivo.  
Potential target genes associated with the SG-specific in vivo CrebA binding sites were 
identified and a GO term analysis was performed to reveal the classes of genes associated with 
CrebA binding. This analysis revealed that TFs and other nucleic acid binding proteins were the 
most enriched, regardless of which dataset intersection was used (Fig. 5,6). These target gene 
classes are inconsistent with previous expression studies that have shown that CrebA primarily 
regulates SPCGs and secretory cargo (Fox et al., 2010), bringing up the question of whether 
binding is always linked to CrebA regulation. CrebA binds almost half of the genes expressed in 
the SG based on BDGP in situ analysis, suggesting that CrebA binding may be linked to open 
chromatin. Consistent with this idea, immuno-staining of SG polytene chromosomes with CrebA 
antiserum reveals that CrebA binds to low DAPI intensity regions (Fig. 7E). Furthermore, a 
CrebA consensus site is associated with between 74.5 and 94.5% of the binding events in the SG 
(depending on which of the three overlapping datasets is analyzed). These observations suggest 
that CrebA binding is a consequence of chromatin accessibility combined with the presence of 
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consensus CrebA binding sites, and that CrebA binding may not always indicate CrebA 
regulation.  
Our in situ analysis of 33 newly tested SG genes – 25 bound by CrebA in the SG and 
eight not bound – supports the idea that CrebA binding and CrebA regulation can be unlinked 
(Table 1, Fig. 8). A breakdown of the 25 genes bound by CrebA in the SG shows some 
interesting patterns. Of the seven SG TFs bound by CrebA (Table 1, green shading), only two 
show reduced expression in the absence of CrebA (sage and Xbp1), and only expression of Xbp1 
was induced in the ectopic stripes of CrebA expression. Of the ten SG SPCGs bound by CrebA 
(Table 1, dark blue shading), most showed reduced expression in the absence of CrebA (8/10) 
and expression of all ten was induced in the ectopic stripes of CrebA expression. The ten genes 
include tbc1 – a gene whose mammalian orthologue was linked to endosomal to TGN trafficking 
while our studies were ongoing. Of the eight SG-expressed genes that were not bound by CrebA 
in the SG, four showed reduced expression in CrebA null SGs but none were activated by ectopic 
CrebA. These findings suggest that (1) CrebA binding is essential for CrebA-dependent ectopic 
expression, (2) CrebA upregulation of a subset of target genes is indirect and possibly through 
either Sage or Xbp1 (the two SG transcription factors whose SG expression was reduced with 
CrebA loss), (3) that a significant subset of SG genes bound by CrebA are not regulated by CrebA 
(6/25 CrebA bound SG expressed genes were completely unaffected by CrebA loss or 
overexpression). This analysis also fully supports a direct role for CrebA in regulation of SPCGs. 
Expression of all of the bona fide SPCGs bound by CrebA (10/10) were ectopically induced in 
the stripes of ectopic CrebA expression. This finding suggests that some of the other genes for 
which CrebA is sufficient for their expression, including Xbp1, TSN, roq, and elF3j, may play 
major roles in secretion. We demonstrate this is the case for Xbp1 and TSN.  
In this study, we also test the importance of the CrebA consensus binding sites for the 
regulation of two new direct targets of CrebA, both of which are shown here to encode regulators 
of secretory capacity, Xbp1 and TSN. With Xbp1, mutations in the two CrebA consensus-binding 
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sites led to loss of CrebA regulation of Xbp1. Both CrebA-dependent endogenous SG expression 
was lost as well as the ectopic stripes of Xbp1 observed with the ectopic striped expression of 
CrebA. We are currently testing if these same mutations result in loss of CrebA binding, which 
we predict will be the case. 
The connection of CrebA to the classic UPR regulator Xbp1 is extremely interesting as 
the physiological role of the UPR is still being elucidated. Many studies of the UPR have been by 
using exogenous application of chemicals such as thapsigargin (Shinjo et al., 2013). While 
invaluable in understanding the mechanisms of the UPR, it is unlikely that the UPR evolved in 
response to chemical perturbation of ER protein folding. Rather, we propose that the UPR exists 
to ensure efficient processing and exocytosis of secreted cargo. Xbp1 activation during UPR 
occurs by alternative splicing by the canonical UPR regulator IRE-1, resulting in a frameshift that 
produces functional Xbp1 (Frakes and Dillin, 2017). Xbp1 is a transcriptional regulator and is 
known to regulate multiple UPR processes including upregulation of chaperone genes. In the role 
as a regulator of UPR, Xbp1 has been implicated in the immune response in C. elegans where 
mutants have decreased survival when exposed to a bacterial pathogen and abnormal ER 
morphology (Frakes and Dillin, 2017). A subset of patients with inflammatory bowel disease 
carry Xbp1 hypomorphic alleles. Loss of Xbp1 during mammalian embryonic development is 
lethal. Rescue in the liver rescues embryonic lethality, but the mice die a few days after birth due 
to secretion defects in both the SG and pancreas. Even heterozygous Xbp1 null mice are not 
perfectly healthy, developing diabetes and other diabetic symptoms such as insulin insensitivity. 
Expression of Xbp1 in neurons can lengthen the lifespan of C. elegans. These studies support a 
model in which the high secretory load in these secretory tissues, induces a form of ER stress, 
which then upregulates Xbp1 and related UPR genes. Considering that Xbp1 has a similar 
binding site motif as CrebA, Xbp1 may work with CrebA to regulate a subset of SPCGs, 
potentially function either as a co-activator or as a downstream TF to activate genes not bound by 
CrebA.  
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TSN has been implicated in many mRNA interactions, including RISC-mediated 
silencing, regulation of non-coding RNAs, and splicing (Gutierrez-Beltran et al., 2016). TSN has 
also been implicated in transcriptional regulation, acting as a co-activator linking TFs with the 
basal transcription machinery such as c-Myb. In this role as a TF, TSN has been linked to cell 
proliferation, differentiation, and death. Increased TSN expression is an indicator of a poor 
prognosis in different cancers. Indeed, TSN is even considered a good marker for breast cancer 
metastasis and it has been suggested that TSN could become a diagnostic or prognostic marker. 
With regards to a role for TSN in secretion, there are two studies in Arabidopsis and one in a 
bovine mammary cell line that show TSN increases secretion through two different mechanisms. 
In Arabidopsis, TSN acts through stabilization of mRNAs encoding secreted proteins (dit Frey et 
al., 2010), whereas TSN transcriptional activity has been implicated in boosting bovine milk 
secretion (Ao et al., 2015). Our work shows that in the embryonic SG, TSN localizes to the ER, 
and not the nucleus (Fig. 12), suggesting that in this tissue, TSN likely acts through mRNA 
regulation rather than transcription. We also show that TSN is required for efficient secretion in 
both the SG and in the epidermal cells that secrete the larval cuticle (Fig. 17) and that the CrebA 
binding sites are required for the secretory function of TSN (Fig 17). Thus, TSN functions at or 
near the ER to boost secretory capacity in a CrebA-dependent manner. Drosophila will be the 
ideal system for parsing out the underlying mechanism for this activity. 
Tbc1 recently was found to function as a bridging factor linking endosomally derived 
vesicles to the TGN (Shin et al., 2017). As such, it was not surprising to find that CrebA is both 
necessary and sufficient for tbc1 expression, since similar regulation patterns have been 
discovered for all other SPCGs that have been examined, with the exception of a subset that are 
only expressed in the SG and nowhere else, such as PH4alphaSG1. It was also not surprising to 
find that loss of Tbc1 is associated with mild secretion defects (Fig. 15, 16, 17). This is discussed 
more in depth in Chapter 2, where we show that the secretion role of Tbc1 is conserved.  
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Altogether, all three of the genes bound by CrebA and examined here have defects 
consistent with each playing a role in secretion. This observation suggests that most, if not all, of 
the genes regulated by CrebA function to increase secretory capacity. Thus, CrebA boosts 
secretory capacity at multiple levels, both through direct regulation of effectors such as tbc1 and 
other SPCGs (Abrams and Andrew, 2005; Fox et al., 2010), and through direct upregulation of a 
transcription factors (Xbp1) and potential regulators of mRNA stability (TSN).  
Most reported studies support a role for the entire CrebA/Creb3L family in boosting 
secretory capacity. Previous studies in Drosophila have linked CrebA to secretory capacity 
(Abrams and Andrew, 2005; Fox et al., 2010; Fox and Andrew, 2015). This study demonstrates 
that CrebA directly regulates most SPCGs as well as regulators of secretion. Others have shown 
that during dendritic arborization, CrebA upregulates the COPII machinery and that loss of 
CrebA or COPII components leads to a drastic decrease in neuronal arborization (Iyer et al., 
2013). A recent study of the innate immune response in Drosophila shows that loss of CrebA 
leads to higher mortality and up-regulation of Xbp1 activation (Troha et al., 2018). Importantly, 
this same study used RNA-seq to reveal that CrebA upregulates SPCGs as well as a subset of 
secreted antimicrobial peptides (AMPs) in the fat body during infection.  
In mice, the closest CrebA homologs Creb3L1 and Creb3L2 have been shown to affect 
osteogenesis and chondrogenesis, respectively (Saito, 2014). Both Creb3L1 and Creb3L2 have 
been shown to regulate expression of COPII components (Keller et al., 2017; Saito et al., 2009). 
Recent work reveals that a point mutation in Creb3L1 leads to familial osteogenesis imperfecta, 
also known as brittle bone disease (Keller et al., 2017). This specific mutation results in secretion 
defects due, in part, to low expression of the COPII component Sec24d. The more specific nature 
of loss-of-function phenotypes of individual Creb3L genes likely reflects the redundant functions 
of this gene family; loss of more than one of the Creb3L genes in mammals is likely to cause 
more profound and widespread defects such as what is observed with loss of the only CrebA gene 
in flies.  
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Materials and Methods  
 
Fly Strains 
 Oregon R was used the wild-type strain. w; UAS-CrebA was provided by S. Smolik (Rose 
et al, 1997), w; fkh-Gal4, and w; Sage-Gal4/CyO, ftz-lacZ, and Sp/ CyO, ftz-lacZ; fkh6 e3/TM6B, 
Ubx-lacZ were developed previously in the Andrew lab (Henderson and Andrew, 2000; 
Loganathan et al, 2016; Wiegel et al 1989). Protein null CrebAwR23 was used as the CrebA mutant 
throughout the text (Andrew et al, 1997). All crosses and collections were performed at room 
temperature (25 oC), unless noted otherwise. The w; en-Gal4 and w; Sp/CyO, ftz-lacZ; prd-
Gal4/TM6, Ubx-lacZ lines are from Wiess et al, 2001 and Bloomington Stock Center 
(Indianapolis, IN; BDSC_1947), respectively. Also from the Bloomington Stock Center 
(Indianapolis, IN) are the lines used for balancing transgenic and other mutated lines: w; 
Sco/CyO, ftz-lacZ and w;; TM3/TM6B, Ubx-LacZ and Sp/ CyO, ftz-lacZ; Dr/TM6B, Ubx-lacZ.  
 
Cloning 
 UAS-CrebA-GFP was cloned using the Gateway Cloning system. The CrebA ORF was 
subcloned from cDNA RE64328 into the pEnterD plasmid using TOPO cloning (Invitrogen). Site 
directed mutagenesis using the QuikChange kit (Aligent) was used to fix a frame shift mutation in 
the ORF by addition of C into position 363 (primer sequences are in Supplemental Table 1). The 
corrected CrebA ORF was then swapped into the pTWG (Gateway Cloning System; Carnegie 
Institution) plasmid using LR Recombination (Invitrogen); this construct adds an in-frame GFP 
ORF to the C-terminus of the CrebA ORF. Rainbow Transgenics, LLC injected this construct into 
w1118 embryos to create the transgenic insertions, which were mapped to specific chromosomes 
using a combination of chromosome-specific balancer lines. See fly strains. 
 To generate the homologous regions (HR) for CRISPR/Cas9 mutagenesis, TOPO cloning 
(ThermoFisher Scientific) was used to insert the genomic region into a plasmid. Site directed 
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mutagenesis of the CrebA binding sites was performed with the QuikChange kit (Aligent). 
Oregon R was the source of the gRNA to generate HR region. Primers are listed in Supplemental 
Table 1.  
 Design of gRNAs for Xbp1 and TSN mutagenesis was done with 
http://tools.flycrispr.molbio.wisc.edu/targetFinder/. The corresponding sequences were 
synthesized as DNA oligos with a 5’ phosphate. Oligos were annealed at 95°C for 5 min and 
allowed to come to room temperature for 10 min (modified from 
http://tools.flycrispr.molbio.wisc.edu/; Gratz et al., 2014). The annealed oligos were ligated into 
linearized and dephosphorylated pU6-2-BbsI-gRNA (DGRC; Bloomington, IN; Stock #: 1363) as 
described in Gratz et al 2014 (http://flycrispr.molbio.wisc.edu/protocols). The entire ligation 
reaction was transformed into 50 μL of chemically competent DH5α E. coli. Injection of the 
gRNA, along with the homologous DNA containing the mutated CrebA consensus binding sites, 
into fly embryos was performed by Rainbow Transgenics, LLC (Camarillo, CA). TSN gRNAs 
and DNAs were injected into y1,sc1,v1; attP40{nos-Cas9}; +/+ embryos and Xbp1 gRNAs and 
DNAs were injected into y1,sc1,v1; +/+; attP2{nos-Cas9} embryos. Two lines each were 
established from each independent F1. Genomic DNA from these stocks was isolated and the 
region of interest was PCR amplified and sequenced to identify lines with mutated CrebA binding 
sites. 
 The homologous recombination knockouts of TSN and tbc1 were performed as described 
previously (Gong and Golic, 2004). Primers used for the HR amplification and cloning as well as 
those used for determining if the knockout occurred at the right locus are in Table X. The HR 
were cloned into the pW25 vector and injected into w1118 embryos by Rainbow Transgenics, LLC 
(Camarillo, CA). The resulting transgenic insertions were mapped to specific chromosomes by 
tracking the white+ eye color marker. An insertion line mapping to a chromosome that does not 
contain the endogenous gene was then crossed to a line expressing the appropriate enzymes for 
excision and linearization of the transgenic construct, as described in Gong and Golic (2003). 
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Potential knockout lines were selected for white+ insertions on the chromosome containing the 
endogenous gene. See Fly Strains for details on the fly lines used.  
 
Antibody Staining 
Embryo fixation and immunohistochemistry were performed as previously described 
(Reuter and Scott, 1990) . Normal goat serum (NGS) was used except for the stains that included 
the donkey secondaries, where normal donkey serum (NDS) was used. Polytene chromosome 
preparations were performed as described previously (Fox et al., 2013). Primary and secondary 
antibodies, concentrations used, and sources are noted in Supplemental Table 2.  
 
In situ hybridization 
In situ hybridization was performed as previously described (Lehmann and Tautz, 1994). 
Antisense RNA probes for the in situ analysis were generated from the cDNA clones indicated in 
Table 1. The Spase12 RNA probe was generated by E. Abrams (Abrams and Andrew, 2005). 
LacZ probes were also included to mark the presence of balancer chromosomes to distinguish 




 Cuticles were prepared as described previously (Fox et al., 2010). Briefly, embryos were 
collected overnight on apple juice caps at 25ºC, dechorionated and aged at 18ºC for ~24 hrs. The 
larvae were transferred to a slide with 1:1 Hoyers:Lactic acid solution. After coverslips were 
placed on larvae, the slides were weighted down and put at 65ºC for 3-4 hrs.  
 
Microscopy 
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All DIC and dark field microscopy was performed on a Zeiss Axiophot 2 with Janoptik 
ProgResC14 Plus optical imaging system. Confocal images were taken with Zeiss AxioObserver 
with LSM700 confocal module (JHMI Microscopy Facility, Baltimore; S10 OD016374). SIM 
was performed on a Nikon SMZ800. 
 
Chromatin Preparation 
Embryo collection and chromatin preparation was performed as described previously 
(Loganathan et al., 2016). Briefly, embryos were collected overnight on apple juice caps at 25ºC 
and fixed in 1.8% formaldehyde for 15 min in a 1:3 solution with heptane. All liquid was 
removed and the fixed embryos were then stored at -80ºC until chromatin preparation. Embryos 
were lysed using a dounce in a 1.8% formaldehyde solution. Chromatin was fragmented by 
sonication and was separated from cellular debris through serial centrifugation. Once isolated, 
chromatin was stored at -80ºC. The immunoprecipitation, sequencing and analysis was performed 
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Drosophila Tbc1 is found in the trans portion of the trans Golgi Network and co-
localizes to a subset of Rabs 
  




 Tbc1d23, a predicted Rab-GAP, has been shown to bridge two Golgins to the WAVE 
complex in the mammalian trans Golgi network (TGN). Through this activity, Tbc1d23 is 
proposed to link endosomally-derived vesicles to their target membrane in the trans Golgi. In 
Chapter 1, we showed that the Drosophila homolog of Tbc1d23 - CG4552/Tbc1 - localizes to the 
trans Golgi, is transcriptionally regulated by the CrebA transcription factor, and that tbc1 loss 
leads to secretion defects. Here, we show that loss of tbc1 also leads to salivary gland apical 
membrane irregularities and that Tbc1 co-localizes with a subset of Rabs, including Rab5 and 
Rab 11. We also demonstrate that Tbc1 does not affect levels of Rab5 or Rab11. 
  




Many organs are organized as epithelial tubes. For example, our entire respiratory, 
circulatory and excretory systems are composed of epithelial tubes, as well as the digestive tract 
and secretory organs. Even the central nervous system begins as an epithelial tube (Colas and 
Schoenwolf, 2001). Epithelial tubes are characterized by an epithelial monolayer often enveloped 
by an outer extracellular matrix (ECM). In some epithelial organs, there is an outer layer of 
supporting cells, such as smooth muscle, and/or an inner (lumenal) ECM (Andrew and Ewald, 
2010). Epithelial cells are connected to each other by adherens junctions, as well as tight 
junctions (vertebrates) or septate junctions (invertebrates), and have apical-basolateral polarity. 
Although the basic organization of epithelial tubes is shared, each tubular organ has unique 
architecture and distinct functions. Consider, for example, the differences between the aorta (a 
relatively simple closed tube) and the lungs (multi-lobed, highly branched tubes). The cellular 
and molecular events underlying formation of these different organs is difficult to study in 
mammals, even in the relatively tractable mouse. On the other hand, the Drosophila embryonic 
salivary gland (SG) provides an excellent model for studying the specification and formation of 
tubular organs. Drosophila is genetically tractable and, with over a hundred years of use as a 
model system, has many useful tools. Importantly, since many transcription factors and signaling 
pathways in Drosophila are found in mammals, what we learn in the fly SG is likely to be directly 
relevant to the formation of human tubular organs.  
Although simple in form, the embryonic SG undergoes several morphological changes 
during its development. The glands begin as a pair of placodes of around 140 cells each on the 
ventral surface of the embryo (Maruyama and Andrew, 2012). These glands invaginate dorsally 
and form an incipient tube, which continues to elongate as more cells internalize. Once the 
salivary gland cells contact the overlying gut mesoderm, they turn and migrate posteriorly. The 
transition from a plate of cells on the surface to a fully internalized and correctly positioned tube 
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is mediated by cell shape changes, cell rearrangement and active migration, with no cell division 
or cell death once the cells are specified to form salivary glands.  
The salivary gland is initially specified by three homeobox transcription factors: Sex 
combs reduced (Scr), Extradenticle (Exd) and Homothorax (Hth) (Henderson and Andrew, 2000). 
These three transcription factors, in turn, activate transcription of additional transcription factors, 
including CrebA.  One of the downstream targets of CrebA binding and activation is CG4552, 
also known as tbc1. Loss of CrebA reduces tbc1 SG expression to the background levels observed 
in surrounding non-SG tissues. Ectopic expression of CrebA in cells that normally express the 
engrailed gene results in the ectopic expression of tbc1 in the same cells.  
Some work has been done with Drosophila tbc1 and its orthologues in other species. For 
example, tbc1 was identified in a large RNAi screen in Drosophila S2 cells, where they showed 
that reduction of tbc1 results in reduced levels of phagocytosis (Stroschein-Stevenson et al., 
2005). Also, knockdown of tbc1in the border cells (BC) of the developing ovary using RNAi 
resulted in slower BC migration (Laflamme et al., 2012). A study looking at innate immunity in 
C. elegans and in vertebrate macrophages suggested a role for Tbc1 orthologues in the innate 
immune response (Alper et al., 2008). Further studies in the murine system revealed a role for 
Tbc1d23 attenuating the innate immune response after initiation. Interestingly, Tbc1d23 is down-
regulated in macrophages infected by P. carinii (De Arras et al., 2012). A more recent study 
showed that Tbc1d23 functions in endosome to Golgi trafficking, linking golgin-97 and golgin-
245 in the trans Golgi to the WASH complex on endosome derived vesicles (Shin et al., 2017). 
There is only a single Tbc1 orthologue in each of the higher eukaryotic species that have been 
studied and the orthologues have very high levels of sequence conservation, suggesting a 
conserved role. To that end, we used the Drosophila embryonic SG to characterize the role of 
Tbc1 in a developmental context. We localize Tbc1 to distinct subcellular domains and carry out 
co-localization experiments with YFP-tagged Rab proteins known to also localize to these 
domains. We demonstrate that loss or overexpression of Tbc1 does not affect the total levels of 
   
75 
 
two of the Rab proteins that colocalize with Tbc1. Finally, we show that loss of tbc1 results in SG 
apical membrane irregularities.  
  




 A BLASTp search with Drosophila Tbc1 identified a single orthologue in each species of 
higher eukaryotes (Fig. 19A). An alignment of the open reading frames (ORF) from a subset of 
these species revealed that the Tbc1 orthologs contain both a Tre1/Bub-2/Cdc-16p (TBC) domain 
and a Rhodanese-like domain (Fig. 19B). Tbc1 is the Drosophila representative of the TBC 
family branch I (Gabernet-Castello et al., 2013). The TBC domain of many family members has 
been shown to have Rab-GAP activity, but Tbc1 and its orthologues lack the key sequence motif 
known to be required for such activity. Thus, it is unclear if Tbc1 acts as a Rab-GAP. It has been 
recently shown that the mammalian orthologue acts as a bridging factor for two trans Golgi 
golgins and endosomally-derived vesicles.  
The Rhodanese-like domain has several potential functions within a cell, including acting 
as a phosphatase, a ubiquitin hydrolase, and a sulfur-transferase (Cipollone et al., 2007). 
Additionally, the presence of the Rhodanese-like domain distinguishes Tbc1 and its orthologues 
from other TBC-containing proteins. There is high conservation throughout the protein among all 
orthologues, both within and outside of the TBC and Rhodanese-like domains. The existence of 
only a single orthologue per species, with very high levels of conservation across the animal 
kingdom, suggests that Tbc1 may have shared functions in all higher eukaryotes.  
In Drosophila, tbc1 transcripts are maternally contributed and transcripts are detectable at low 
levels in all cells of the developing embryo (Fig. 19C). Tbc1 is also transcriptionally upregulated 
in the SG, proventriculus, and hindgut. Upregulation in the SG begins early, when the SG is first 
specified, and continues throughout embryogenesis. Because Tbc1 is expressed in the Drosophila 
SG, we decided to use this tissue to investigate the normal physiological role of Tbc1.  
 A single P-element insertion line was available for tbc1, but the insertion was in 
an intron and had no effect on Tbc1 expression (data not shown). To generate a null mutation of 
tbc1, we used homologous recombination to replace the ORF with the white+ (w+) eye color gene 
(Fig. 13). The tbc1 null mutants were verified using PCR and in situ hybridization (Fig. 13). We   
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Figure 19: Drosophila Tbc1 is highly conserved and is expressed dynamically in embryos A) 
Unrooted tree of Tbc1 orthologues constructed by the Protein Tools (previously) available 
through the San Diego Supercomputer (http://workbench.sdsc.edu/). Asterisks indicate species 
included in the alignment. B) Alignment of Tbc1 orthologues. Red bar indicates the TBC domain, 
purple bar the Rhodanese-like domain. Green residues indicate conservation in all species. 
Yellow residues are the same many species and the cyan residues indicate similarity. C) mRNA 
accumulation pattern of tbc1 in embryos. Whole-mount in situs with probes detecting tbc1 
mRNA in wild-type embryos. Black arrows, salivary gland; white arrows, proventriculus; 
arrowhead, hindgut. In stage 17, there is hindgut expression that is not visible in the focal plane 
shown.  
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stained tbc1 null embryos with an apical membrane marker and discovered that the SGs had 
between ~10% to ~50% apical membrane irregularities (Fig. 20). Trans-heterozygotes of the tbc1 
null and a deficiency that removes Tbc1 and several nearby genes had similar rates of apical 
membrane defects. Maternal loss of tbc1 had no additional effect on the apical membrane defects, 
suggesting that it is the zygotic contribution of tbc1 that is important for SG morphology. Egg 
chamber development and border cell migration were also examined, but no overt defects were 
noted (data not shown).  
 To determine where Tbc1 localizes within a cell, we overexpressed a C-terminal GFP-
tagged version of Tbc1 in the SG using a Fkh-Gal4 driver. We stained for GFP and a variety of 
organellar markers. Tbc1 did not co-localize with the ER or with Csp, a marker for general 
secretory vesicles (Fig. 21A-B), but partially colocalized with recycling endosomes marked by 
Rab11 (Fig. 21C).  
  We subsequently developed a rat Tbc1 antiserum that detects Tbc1 with both 
immunohistochemistry and Western blotting (Fig. 22, 23). Using fluorescent confocal 
microscopy, we determined that endogenous Tbc1 stains in a punctate pattern in the cell, similar 
to the staining observed with GFP immunostaining of Tbc1-GFP expressed in the SG (Fig. 23). 
Staining with the Tbc1 antiserum in tbc1 null embryos revealed low level non-specific staining 
near the SG apical membrane (Fig. 23A). Wild-type SGs have higher levels of apical membrane 
staining, suggesting that there is a pool of Tbc1 on or near the apical surface. As discussed in 
Chapter 1, endogenous staining of Tbc1 with Golgin-245 (trans Golgi marker) and GM130 (cis 
Golgi marker) showed Tbc1 did not colocalize with GM130 but partially colocalized with 
Golgin-245 (Fig. 14). In particular, there are multiple examples where we observe close staining 
of GM130 and Golgin-245, with close staining of Golgin-245 and Tbc1 (with a subset of Tbc1 
overlapping with Golgin-245). This staining pattern is consistent with Tbc1 localizing to the trans 
most part of the TGN, where sorting of recycling endosomes occurs. We conclude that Tbc1 
localizes  to  recycling  endosomes  and  the  TGN,  suggesting  that  Tbc1  could  be  involved  in  the  
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Figure 20: Loss of tbc1 results in irregular apical membrane surfaces in the salivary gland. 
A-D) Crb staining outlines the apical/lumenal surface. The salivary gland is outlined in each 
panel. Arrowheads indicate apical membrane irregularities. A) Wild-type, B) tbc1 homozygous 
knockout, maternal-zygotic loss, C) Tbc1 knockout over a deficiency that removes tbc1, 
maternal-zygotic loss, D) zygotic loss of Tbc1 in knockout over the deficiency. E) Quantification 
of A-D; n indicates the number of salivary glands counted. ***: p<0.000001. 
  



















Figure 21: Tbc1 does not co-localize to dCSP or SG2 and partially colocalizes with Rab11. 
UAS-Tbc1-GFP driven by fkh-Gal4 and immuno-stained for GFP (Green). A) Costaining with 
the ER marker SG2 (Red). B) Costaining with the secretory vesicle marker dCSP1 (Red). C) 
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Figure 22: HRP and Western blotting using Tbc1 antiserum. A) Immunostaining with HRP. 
Staining is with the final bleed of Rat αTbc1 used at a dilution of 1:1000. Secondary was Rabbit α 
Rat-Biotin 1:500. B) HRP Immunohisochemistry and Western blotting with Tbc1 antiserum. A) 
HRP staining of embryos in Tbc1Null, wild type and SG overexpression of untagged and GFP 
tagged Tbc1 using Tbc1 antiserum. SG is outlined with dashed line. B) HRP staining of GFP 
tagged Tbc1 overexpressed in the SG using GFP antibody. SG is outlined with dashed line. C) 
Western blotting for Tbc1 (top), GFP (middle) and βtub (bottom). Full length, untagged Tbc1: 
77.5kDa; Full length, GFP tagged: 106.7kDa. Wild type: OR; Untagged: tub-Gal4>UAS-tbc1; 
Tagged: tub-Gal4>UAS-tbc1-GFP. Black arrowhead: Untagged Tbc1 size; Green arrowhead: 
expected size of GFP tagged Tbc1; *: non-specific bands.   








Figure 23: Fluorescent confocal images of using Tbc1 antibody. A) Tbc1 staining in wild type 
and Tbc1Null. Tbc1 alone is shown in left hand panels and merge with DAPI (blue) and GM130 
(red) on right. B) Tbc1 (purple) and GFP (green) staining of untagged (top) and GFP-tagged 
overexpressed Tbc1 in the SG. GFP and Tbc1 staining fully overlap in salivary glands 
overexpressing Tbc1-GFP. Blue: DAPI. 
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sorting of cargo destined for the apical membrane.  
 Because Tbc1 is a predicted Rab-GAP, we wanted to determine which, if any, Rabs 
might colocalize with Tbc1. Due to Tbc1’s cytosolic localization, we focused on 19 of the more 
than 30 Rabs known to exist in flies. We expressed both untagged UAS-Tbc1 and UAS-YFP 
tagged forms of each of the Rabs in the SG using a fkh-Gal4 driver line (Zhang et al., 2007). For 
Rab7, we used UAS-Rab7-GFP. Of the 19 Rabs we tested, only a subset – Rab-X1, -5, -8, -9, and 
-10 – partially colocalized with Tbc1 (Fig. 24, 25).  
 Shin et al, 2017 showed that Tbc1d23 has a role besides the predicted Rab-GAP function, 
chiefly that it acts as a bridging factor in the TGN. Another possible role, suggested by the 
presence of the Rhodanese-like domain, is that Tbc1 could be involved in the degradation of 
interactors. The Rhodanese-like domain has many potential roles within the cell, one of which is 
hydrolyzing ubiquitin. Classically, ubiquitination can lead to degradation of targeted proteins. To 
ask if Tbc1 affected protein levels of Rab 5 or Rab11, we did Westerns and compared the levels 
of Rab5 and Rab11 in WT and tbc1 null embryos (Fig. 26). We did not observe any overt 
differences in the levels of either Rab suggesting that Tbc1 is not involved in the synthesis or 
degradation of either Rab.  
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Figure 24: Partial Colocalization of Tbc1 with a subset of Rabs. Tbc1: purple; YFP-Rab: 
Green; DAPI: Blue. UAS-Tbc1 and UAS-YFP-Rab were overexpressed using a fkh-Gal4 driver 
on chromosome II that has mosaic expression in the SG. 
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Figure 25: Tbc11 does not colocalize with a subset of Rabs. Tbc1: purple; YFP-Rab or GFP-
Rab: Green; DAPI: Blue. UAS-Tbc1 and UAS-YFP-Rab (or, in the case of Rab7 UAS-GFP-
Rab7) were overexpressed using a fkh driver on chromosome II that has mosaic SG expression. *: 
non-specific binding of Tbc1. 
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Figure 26: Tbc1 loss or overexpression does not lead to changes in Rab5 or Rab11 levels. A) 
Rab5 with Western using LI-COR and βtub with chemiluminescence. B) Rab5 with Western 
using LI-COR and βtub with chemiluminescence Black arrowhead: Rab; White arrowhead: βtub.  
  








 Tbc1 has a clear orthologue in all higher eukaryotes (Fig. 18A) and the proteins are very 
highly conserved (Fig. 18B). The key characteristic of this family is the combination of the TBC 
domain (the Rab-GAP domain) and the Rhodanese-like domain. Due to the Rhodanese-like 
domain, there was a possibility that Tbc1 might prevent the degradation of interacting Rabs, as 
the domain can function as an ubiquitin hydrolase. We determined that neither Rab5 nor Rab11 
protein levels changed in whole embryo lysates of wild type, tbc1 loss, or tbc1 overexpression 
(ubiquitously or SG-specific; Fig. 26), suggesting that Tbc1 does not play a role in the steady 
state levels of Rabs.   
In Drosophila, Tbc1 is expressed ubiquitously but is also upregulated in multiple 
secretory tissues, such as the SG (Fig. 18C). SG expression of tbc1 requires CrebA and CrebA is 
sufficient to induce ectopic tbc1 mRNA expression (Fig. 8). Using a marker for SG secretion and 
cuticle preps, we show that loss of tbc1 affects both SG and cuticle secretion. Since similar 
defects are observed with all other secretory pathway component gene (SPCG) mutations we 
have tested, these findings support a role for Tbc1 as an SPCG.  
Recently, the mammalian homolog of Tbc1, Tbc1d23, was found to be a bridging factor 
in the TGN (Shin et al., 2017), connecting Golgins that localize to the trans Golgi with the 
WASH complex. Mutations in Tbc1d23 were also recently linked to Pontocerebellar hypoplasia 
(PCH) (Ivanova et al., 2017; Marin-Valencia et al., 2017). Ivanova et al (2017) showed that loss 
of Tbc1d23 in fibroblasts led to lysosomal trafficking and dense core vesicles defects. 
Additionally, in HeLa cells, Arl1 and Arl8 control Tbc11d23 levels at the TGN (Marin-Valencia 
et al., 2017). Like Tbc1d23, Tbc1 localizes to the trans-Golgi, specifically to the trans most 
portion of the TGN (Fig. 14). Using antibodies and YFP tags, we showed that Tbc1 partially 
colocalizes with six different Rabs (Fig. 21,24). Five of the six are known to localize to recycling 
endosomes. The one that is not, Rab5, has been localized to the early endosomes. Rab9 localizes 
to both recycling and early endosomes, as well as the TGN and late endosomes (Fig.24). 
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Altogether, this localization analysis supports the idea that Tbc1 and its homologs are involved in 
the targeting of vesicles to/from recycling endosomes and the TGN.  
Other studies have hinted at an SPCG role of Tbc1 and its homologs. Using RNAi against 
Tbc1, Stroschein-Stevenson et al. (2005) showed that knockdown of tbc1 led to a decrease in 
overall phagocytosis. One reason for this might be that cargo targeted to the phagocytosing 
membrane is mistargeted and/or slowed, preventing phagocytosis from occurring at normal rates. 
In C. elegans and mouse studies, loss of tbc1 homologs led to longer innate immune responses to 
bacterial infection (Alper et al., 2008; De Arras et al., 2012). In tbc1 homolog knockout mice, it 
was found that the IL-6 cytokine was secreted at reduced levels and that the issue was not 
initialization of the innate immune response but rather the maintenance of high cytokine levels. A 
key part of the innate immune response in all animals is the secretion of antimicrobial peptides 
and/or cytokines. Loss of Tbc1 acting as bridging factor could lead to slower exocytosis. The 
TGN is central in targeting of vesicles to different organelles and areas of the plasma membrane 
and the loss of Tbc1 as a bridging factor could lead to mistargeting of vesicles and/or slower 
vesicular exit from the TGN, thus affecting secretion.  
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Materials and Methods 
 
Fly Strains 
 Oregon R was used the wild-type strain. w; fkh-Gal4 was developed previously in the 
Andrew lab (Henderson and Andrew, 2000). All crosses and collections were performed at 25ºC, 
unless noted otherwise. From Bloomington Stock Center (Indianapolis, IN) for balancing and line 
isolation: w; Sco/CyO, ftz-lacZ and w;; TM3/TM6B and Sp/ CyO, ftz-lacZ; Dr/TM6B, Ubx-lacZ. 
All YFP-Rab (Zhang et al., 2007) lines are noted in Table 2 and were obtained from Bloomington 
Stock Center (Indianapolis, IN). 
 
Cloning 
UAS-tbc1 and UAS-tbc1-GFP was cloned using the Gateway Cloning system. The tbc1 
ORF was subcloned from cDNA AT03044 into the pEnterD plasmid using TOPO cloning 
(Invitrogen). The tbc1 ORF was then swapped into the pTW or pTWG (Untagged or GFP, 
respectively; Gateway Cloning System; Carnegie Institution) plasmid using LR Recombination 
(Invitrogen). The pTWG construct adds an in frame GFP ORF to the C-terminus of the tbc1 ORF. 
Rainbow Transgenics, LLC injected this construct into w1118 embryos to create the transgenic 
insertions, which were mapped to specific chromosomes using a combination of chromosome-
 
Table 2: GFP/YFP Tagged Rab stocks utilized. 
Rab Stock Number Stock Genotype Identifier Citation







RRID:BDSC_9793 Zhang et al 2007
Rab18 9796 y1 w*; P{UAST-YFP.Rab18}CG977501 RRID:BDSC_9796 Zhang et al 2007
Rab19 24150 y1 w*; P{UAST-YFP.Rab19}Hr3902 RRID:BDSC_24150 Zhang et al 2007
Rab21 23242 y1 w*; P{UAST-YFP.Rab21}pog04 RRID:BDSC_23242 Zhang et al 2007
Rab23 9802 y[1] w[*]; ; P{w[+mC]=UASp-YFP.Rab23}01 RRID:BDSC_9802 Zhang et al 2007
Rab26 23245 y[1] w[*]; P{w[+mC]=UAST-YFP.Rab26}05/CyO RRID:BDSC_23245 Zhang et al 2007
Rab30 9812 y1 w*; P{UASp-YFP.Rab30}Cdk410 RRID:BDSC_9812 Zhang et al 2007
Rab35 9821 y
1
 w*; P{UASp-YFP.Rab35}15 RRID:BDSC_9821 Zhang et al 2007












/CyO RRID:BDSC_23251 Zhang et al 2007
Rab7 42705 w*; P{UAS-Rab7.GFP}2 RRID:BDSC_42705 Bellen, H. (2012.12.5). Bellen insertions. 
Rab8 9782 y1 w*; P{UASp-YFP.Rab8}45 RRID:BDSC_9782 Zhang et al 2007
Rab9 9784 y1 w*; P{UASp-YFP.Rab9}22 RRID:BDSC_9784 Zhang et al 2007
RabX1 9840 y1 w*; P{UASp-YFP.RabX1}12 RRID:BDSC_9840 Zhang et al 2007
RabX4 9851 y1 w*; P{UASp-YFP.RabX4}how19 RRID:BDSC_9851 Zhang et al 2007
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specific balancer lines. See fly strains. 
For bacterial induction, the C-terminal region of tbc1 ORF (amino acids 321-689) from 
AT03044 was subcloned into pET15b using In-Fusion HD Cloning Kit (Invitrogen; primers in 
Supplemental Table 1).  
 
Antibody Staining 
Embryo fixation and immunohistochemistry were performed as previously described 
(Reuter et al., 1990). Antibodies, their concentration, source and use are found in Supplemental 
Table 2.  
 
In situ hybridization 
In situ hybridization was performed as previously described (Lehmann and Tautz, 1994). 
Antisense RNA probes were directed to the entire coding region of Tbc1.  
 
Antiserum Generation 
 pET15b-tbc1 was transformed into BL21-DE3 cells. Induction occurred once the cells 
reached 0.77AU with 0.1M IPTG and cells were grown at 37°C for another 4 hours. Inclusion 
body prep was performed to isolate the C-terminal region of Tbc1 as described previously 
(Hanlon and Andrew, 2016). The resulting protein prep was sent to Covance (Denver, PA) for 




 Western blotting was done as described previously (Ismat et al., 2013). 10% SDS-PAGE 
gels were used to size separate protein from whole embryo lysates. The size-separated proteins 
were then transferred to a polyvinylidene difluoride (PVDF) membrane and blotted as described 
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previously. If the blot was for LI-COR, the protocol was performed as described, only with the 
Odyssey Blocking Buffer (PBS) substituted. Licor Odyssey CLx was used for imaging the Licor 
blots. Antibodies used, along with concentration and source are found in Supplemental Table 2.  
 
Microscopy 
Confocal microscopy was performed on a Zeiss AxioObserver with 780-Quasar confocal module 
& FCS (NIH Grant S10 OD016374) or, Zeiss AxioObserver with LSM700 confocal module 
(NIH Grant S10 OD016374) or Zeiss Axiovert 200 with 510-Meta confocal module. All DIC 
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The generation and testing of GFP tagged fork head, Sage, and sens for ChIP-seq 
  




 Fkh, Sage, and Sens are transcription factors (TFs) that play key roles in the developing 
Drosophila embryonic salivary gland. All three are required for salivary gland survival and full 
levels of expression of salivary gland specific gene products.  Fkh plays an additional role in 
regulating the process of morphogenesis – creating a three dimensional tube from the two 
dimensional salivary gland primordia.  To determine how these proteins interact with chromatin 
and with each other to control salivary gland specific gene expression and to identify direct 
downstream target genes, we are expressing GFP tagged forms of these TFs in the embryonic SG 
and performing ChIP-seq using a GFP antibody.  So far, we have generated lines expressing 
GFP-tagged version of all three TFS.  We have shown that the GFP tagged TFs are fully 
functional; their overexpression phenocopies overexpression of untagged forms of the same 
proteins, and the GFP tagged TFs can rescue loss-of-function phenotypes. We have isolated 








The Drosophila salivary gland is initially specified by three homeobox transcription 
factors: Sex combs reduced (Scr), Extradenticle (Exd) and Homothorax (Hth) (Fig 1) (Henderson 
and Andrew, 2000). These three transcription factors in turn activate transcription of four 
additional transcription factors: CrebA, Huckebein (Hkb), Sage, and Fork head (Fkh) (Maruyama 
et al., 2011). The salivary gland expression of Scr, Exd and Hth is transient; expression is turned 
off during early stages of salivary gland invagination (Henderson and Andrew, 2000). Thus, the 
role of Scr-Exd-Hth is to initiate salivary gland specification.  
The four transcription factors activated by Scr, Exd and Hth are responsible for the 
morphology, survival, and function of the salivary gland. CrebA was discussed previously. The 
Sp1/Egr-like transcription factor Hkb, unlike all the other salivary gland transcription factors, is 
expressed only transiently in the salivary gland (Myat and Andrew, 2000a; Myat and Andrew, 
2002) and its expression is turned off in the salivary gland shortly after invagination begins. 
Hkb’s role in the salivary gland is in tube elongation. In hkb mutants, apical vesicular trafficking 
is defective, leading to salivary glands that are much shorter than in wild type. Overexpression of 
Hkb leads to the opposite phenotype of normally-elongated salivary glands with expanded apical 
lumens. 
Sage, unlike all the other known transcription factors involved in salivary gland 
specification, is only expressed in the salivary gland (Chandrasekaran and Beckendorf, 2003). 
This basic helix-loop-helix transcription factor works with Fkh to control expression of salivary 
gland-specific genes. Indeed, Sage is what confers tissue specificity to Fkh in the salivary gland 
(Fox et al., 2013). One known target of Fkh/Sage is another transcription factor, known as 
Senseless (Sens) (Chandrasekaran and Beckendorf, 2003; Fox et al., 2013). Sens increases the 
expression levels of Fkh-Sage target genes(Fox et al., 2013). The targets of Sage, Fkh and Sens 
include tissue-specific secreted gene products and modifying enzymes, suggesting that these 
transcription factors work together to regulate high-level production of gene products unique to 
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the salivary gland. Fkh also appears to work with Sage and Sens to block apoptosis of SG cells, 
which cease dividing once they are specified (Chandrasekaran and Beckendorf, 2003; Fox et al., 
2013; Myat and Andrew, 2000b). 
Fkh has additional roles in salivary gland development that are not shared with Sage and 
Sens. Importantly, this includes driving the cell shape changes and cell rearrangements required 
to transform the two dimensional SG primordia into an elongated tube (Chung et al., 2017; Myat 
and Andrew, 2000b; Sanchez-Corrales et al., 2018). Interestingly, Fkh is also required to maintain 
expression of itself, CrebA and Sage after expression of Scr/Exd/Hth is turned off in the salivary 
gland. Although many downstream genes have been identified for Hkb, Sage, Fkh and Sens, the 
list of targets is almost certainly incomplete and whether known targets are directly regulated by 
Hkb, Sage, Fkh and Sens is unknown.  Additionally, Fox et al 2013 hypothesized that Fkh, Sage 
and Sens act in a complex to activate expression of SG-specific genes and they showed that all 
three TFs bind to the same cytological locations on SG polytene chromosomes (Fig. 27).   
To reveal the direct downstream targets of Fkh, Sage and Sens, all were tagged with GFP 
in preparation for salivary-gland specific ChIP-seq using the same protocol as was used with 
CrebA, which was described in Chapter 2.  Further analysis of these lines showed that the GFP 
Figure 27: Fkh, Sage, and Sens pathway. modified from Fox et al, 2013.  
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tagged forms had similar defects when overexpressed as untagged versions of the proteins and 
they also could rescue the SG mutant phenotypes.  Chromatin was prepared from lines expressing 
the GFP tagged versions of the three proteins expressed in the SG using two distinct Gal4 drivers 
that have in common expression in the embryonic SG.  The chromatin was sent to our 
collaborator Matthew Slattery at The University of Minnesota, Duluth, and we are awaiting the 
ChIP-seq results.   
  




With the exception of Sage, all of the other known transcription factors that regulate 
salivary gland development are also expressed in other tissues.  Consequently, we tagged fkh, 
sage, and sens with a C-terminal GFP and expressed the tagged forms in a tissue specific manner 
using fkh-Gal4 and sage-Gal4 (Fig. 28). Neither driver is SG specific but they have only 
expression in the SG in common.  Using both drivers, we can determine the SG specific targets of 
the TFs as the intersection of the binding sites from both drivers.  Additionally, since Sage is SG 
specific, we can perform ChIP-seq pulling down with a Sage antiserum developed in the Andrew 
lab using chromatin from wild-type embryos as a control. 
To ensure the GFP tagged TFs are fully functional, we overexpressed both the untagged 
and GFP-tagged forms of each protein in an otherwise WT background and showed that the 
construct expressing the tagged versions result in the same phenotype as the untagged constructs 
(Fig. 29). For these experiments, a ubiquitous driver (tub-Gal4) was used and the embryos were 
stained for SG2 (an SG specific ER-resident protein).  For sage, the overexpression embryos were 
fairly normal except that SG2 expression expanded into the SG duct and hindgut (Fig. 29A). This 
was observed previously with the untagged overexpression construct (Fox et al., 2013).  
Expression of Fkh or Sens led to gross morphological defects such as SGs that are not fully 
internalized and germband retraction defects (Fig. 29B, C)    
To further test the functionality of the tagged versions of these transcription factors, we 
have rescued the loss-of-function phenotypes of fkh, sage, and sens (Fig. 30). Loss of any of these 
transcription factors leads to death of the SG cells. This is observed quite early with loss of Fkh 
(Fig. 30A), where the entire SG is lost at by embryonic stage 12 and is fully rescued by Fkh-GFP.  
When sage is knocked out, SG cells undergo massive apoptotic death at a slightly later embryonic 
stage (Fig. 30B).  SG expression of Sage-GFP leads to full rescue of SG viability.  The SG of a 
sens mutant embryo also undergoes late apoptosis resulting in a much smaller and lightly stained 
SG (Fig. 30C); the SG is the SG is completely normal when sens-GFP is expressed in the SGs of    
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Figure 28: anti-GFP staining of all three constructs using Fkh-Gal4 (A) and Sage-Gal4 (B).  
A) Fkh-Gal4: can see expression of GFP in the SG, hemocytes and peripheral nervous system.  B) 




Figure 29: Tub-Gal4 overexpression of untagged and GFP-tagged Fkh, Sage, and Sens. A) tub-Gal4>UAS-fkh-GFP overexpression, there is 
a failure of germband retraction and SG internalization.  B) tub-Gal4>UAS-sage-GFP overexpression, SG2 expression is expanded to duct and 
hindgut cells.  C) tub-Gal4>UAS-sens-GFP overexpression, germband retraction and SG internalization has failed. Black arrowhead: SG; White 
arrowheads: the ectopic expression of SG2 in the hindgut.  Black arrows: failure of germband retraction.
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Figure 30: SG rescue of TF mutant phenotypes by SG-specific expression of GFP tagged TFs. A) Sage staining of fkh mutant and (‘) rescues.  
B and C) CrebA staining of B) sage, and C) sens mutants and (‘) rescues.  sage and sens mutants are also stained with β-Gal and are siblings of the 






sens mutants.  Thus, both 
the gain-of-function assays 
and the rescue of SG defects 
demonstrate that the GFP 
tagged form of fkh, sage, 
and sens are fully 
functional.  
We also tested 
whether the Sage antisera 
recognizes Sage-GFP by 
overexpressing it using an 
en-Gal4 line, which drives 
expression of transgenes 
containing a UAS promoter 
in stripes along the embryo (Figure 31). Conveniently, this antisera was previously used for ChIP-
qPCR (Fox et al., 2013), suggesting that it will work well for the ChIP-seq experiments.   
Three independent chromatin samples per genotypes have been collected from embryos 
expressing the GFP-tagged version of all three proteins under the control of two Gal4 lines that 
have only salivary gland expression in common.  We have also obtained three independent 
chromatin samples from WT embryos, which will be immuno-precipitated for ChIP-Seq using the 
Sage antiserum, serving as an independent control for the Sage-GFP binding.  All of the 
chromatin samples and the Sage antiserum was shipped to our collaborators at the University of 
Minnesota, Duluth.  We are currently waiting for them to complete the ChIP-Seq analysis and 
send us the resulting data to continue our analysis.   
 
 
Figure 31: anti-Sage staining of en-Gal4 driven Sage-GFP.  
Arrows indicate expression in the en-Gal4 domains.  SG has 
not been specified at this stage. 




 Future work will include ChIP-seq analysis using a well-tested GFP antibody to isolate 
chromatin from embryos expressing GFP tagged forms of three TFs: Fkh, Sage, and Sens, key 
TFs involved in the survival and function of the SG.  Fkh has additional roles in SG 
morphogenesis.  For our experiments, two Gal4 drivers that have only SG expression in common 
were used, thus enriching for SG-specific DNA binding events (Fig. 27). We have shown that the 
GFP tagged versions of each protein result in the same phenotypes when expressed ectopically as 
observed with the corresponding untagged versions (Fig. 28).  We also showed that the GFP-
tagged versions can rescue the SG specific phenotypes of the respective loss-of-function mutants 
(Fig. 29).  Finally, with Sage we are able to show that the Sage antibody we intend to use as a 
control detects Sage-GFP when it is ectopically expressed in en stripes (Fig. 30). We have sent 
the chromatin to our collaborator at the University of Minnesota and are awaiting the resulting 
data from the ChIP-seq.  
When comparing our GFP ChIP-seq data sets to existing published datasets (Negre et al 
2011), we generally expect only a limited group of genes will be found in both. This is because 
we expect the other datasets to include genes under the control of the transcription factor in 
tissues other than the salivary gland. An exception to this rule is the dataset we generate using our 
Sage antisera. For the Sage datasets, we expect to find a one to one relationship since Sage is 
expressed in only the salivary gland.   
Comparing our GFP datasets amongst themselves we expect to see binding overlap at 
some loci as it has been hypothesized that Fkh, Sage, and Sens work in a complex.  Using known 
binding site motifs and analysis of the binding peaks we may determine the binding site 
requirements for the complex or individual TF to regulate downstream targets.  We do expect that 
a subset of genes will not be bound by the complex but the individual TFs. Particularly because it 
is known that Fkh plays a separate role in the morphogenesis of the SG.   
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When we compare our data with existing microarray data (Fox et al, 2013; Maruyama et 
al, 2011; Liu and Lehmann, 2008), we expect to find many shared genes. The direction of the fold 
changes in the microarray will indicate if the transcription factor acts as an activator or repressor 
for each target. We will conclude that genes that are found to be targets in the microarray but not 
the ChIP-seq will be indirect targets of the transcription factor. Candidate target genes from the 
ChIP-seq not found in the microarray sets will be tested for regulation by performing similar in 
situ experiments as in Chapter 1.  mRNA expression in wild-type embryos will be compared to 
mRNA expression in TF mutant embryos and embryos with overexpression of TF-GFP in en 
stripes. We may discover that although the transcription factor binds the DNA in the salivary 
gland, that regulation may be in other tissues because of additional requirements for cell-type 
specific regulators. 
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Materials and Methods  
 
Fly Strains 
 Oregon R was used the wild-type strain.  w1118;UAS-fkh, w1118;UAS-sage, w1118;UAS-sens, 
w1118;fkh-Gal4, and w1118;Sage-Gal4/CyO, ftz-lacZ were generated previously in the Andrew lab 
(Abrams et al., 2006; Fox et al., 2013; Henderson and Andrew, 2000).  All crosses and collections 
were performed at 25ºC, unless noted otherwise. The w;en-Gal4 is from Weiss et al., (2001). The 
following stocks were used for balancing transgenic and mutant lines: w;Sco/CyO,ftz-lacZ and 
w;TM3/TM6B,Ubx-lacZ and Sp/CyO,ftz-lacZ; Dr/TM6B,Ubx-lacZ.   
 
Cloning 
 UAS-fkh-GFP, UAS-sage-GFP, and UAS-sens-GFP were cloned using the Gateway 
Cloning system.  The fkh ORF and sage ORF were subcloned from cDNA RE03865 and 
RE59356, respectively, into the pEnterD plasmid using TOPO cloning (Invitrogen). UAS-sens 
(Nolo et al., 2000) flies were used as a template to amplify the ORF using primers: CS00 and 
CS01 (Table X). Site directed mutagenesis using the QuikChange kit (Aligent) was used to fix 
mutations in the ORF of fkh: T302C, G694A, and insertion of C into position 1274 (primer 
sequences are in Supplemental Table X). The corrected fkh, sage, and sens ORFs were then 
swapped into the pTWG (Gateway Cloning System; Carnegie Institution) plasmid using LR 
Recombination (Invitrogen); this construct adds an in frame GFP ORF to the C-terminus of the 
TF ORF. Rainbow Transgenics, LLC injected each construct into w1118 embryos to create the 
transgenic insertions, which were mapped to specific chromosomes using a combination of 
chromosome-specific balancer lines. See fly strains. 
 
Antibody Staining 
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 Embryo fixation and immunohistochemistry were performed as previously described 
(Reuter and Scott, 1990).  All antisera used in this analysis, as well as the concentration and 
source of the antisera are listed in Supplemental Tables 2 and 3. All DIC microscopy was 
performed on a Zeiss Axiophot 2 light microscope equipped with a CCD camera.  
 
Chromatin Preparation 
Embryo collection and chromatin preparation were performed as described previously 
(Loganathan et al., 2016).  Briefly, embryos were collected overnight on apple juice caps at 25ºC, 
rinsed and fixed in 1.8% formaldehyde for 15 min in a 1:3 solution with heptane.  The liquid was 
removed and the fixed embryos were then stored at -80ºC until the chromatin preparation.  
Embryos were lysed during thawing using a dounce in a 1.8% formaldehyde solution.  Chromatin 
was fragmented by sonication and separated from cellular debris through serial centrifugation.  
Once isolated, chromatin was stored at -80ºC and was shipped on dry ice.   
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Continued on next page 
Primer Name Primer Sequence Use of primer
DJ052 GTACCTCACCTTCCACGTCCCGCCcACGCACGCCACGCCCATC Site directed repair mutagenesis of CrebA; Forward
DJ053 GATGGGCGTGGCGTGCGTgGGCGGGACGTGGAAGGTGAGGTAC Site directed repair mutagenesis of CrebA; Reverse
CS02 cacc ATGGAATTCTACGATGGCGACC Cloning of UAS-CrebA-GFP; Forward
CS03 GGACTTTTTCACATTGTGCTTGC Cloning of UAS-CrebA-GFP; Reverse
Primer Name Primer Sequence Use of primer
2R:21143405 TAAGATATTGCCTGAAATGTTAC HR amplification primers for Xbp1 ; forward
2R:21143758 CGTCTCATGAACTTCGACTGC HR amplification primers for Xbp1 ; reverse
Xbp1 5' Mut primer CCAACTCTTCTAGAAAAACgttgtAGCTTTTCACAGCCATTCG Mutagenesis primer for Xbp1
Xbp1 5' Mut primer GCTTTTCACAGCCATTCGGAAAAGAACgttgtAGCAGAAAGGAAAACTGGTC Mutagenesis primer for Xbp1
2R:21143639 CTTCGTCGGTCGATATTGCAAAGG gRNA oligo cloning sequence Xbp1 forward
2R:21143653 AAACCCTTTGCAATATCGACCGAC gRNA oligo cloning sequence Xbp1 reverse
Primer Name Primer Sequence Use of primer
3L:264146 CAAAGTCGTTGTCCGGCATTG HR amplification primers for TSN ; forward
3L:263300 GTGTTACTGATAAGGGCGTCAG HR amplification primers for TSN ; forward
TSN 5' Mut Primer 
#1
ACTCTGTGCGTGTGTGACcaacTGCACACGCTGTCCGATCACGCTGTCCG Mutagenesis primer for TSN Binding Site 1
3L:264023 CTTCGAAAGTTCGTCCAAACTAAG gRNA oligo cloning sequence TSN forward
3L:264045 AAACCTTAGTTTGGACGAACTTTC gRNA oligo cloning sequence TSN reverse
Primer Name Primer Sequence Use of primer
CG4552_5L GGGCGGCCGCCGACAAATAACACTTGTGGAAGTC 5' HR Region for tbc1 ; forward
CG4552_5R GGGGTACCTAAGGTTATTCAGCGGGATCTAAG 5' HR Region for tbc1 ; reverse
CG4552_3L GGGGCGCGCCTCATCACGTTCAAGTACGGATTC 3' HR Region for tbc1 ; forward
CG4552_3R GGCGTACGGTAGGTTCCCGTGTGCTTG 3' HR Region for tbc1 ; reverse
CG4552 KO gggttgggatgggttggggc Diagnostics: Upstream of HR for tbc1  KO; forward
DJ015 cacacacactcacaaaggagg Diagnostics: Downstream of HR for tbc1  KO; reverse
DJ066 cgcgcggcagccatatg ACAGAGTTTCCTGTGCCGGATG Tbc1 cloning into pET15b protein expression; forward
DJ050 ccggatcctcgagcatatg CTACTTGGCGTCGTCAAGCACC Tbc1 cloning into pET15b protein expression; reverse
DJ042 cacc ATGGAGGAGAATATGTGGATC Tbc1 cloning into pENTRD vector; forward
DJ043 CTACTTGGCGTCGTCAAGCACC Tbc1 cloning into pENTRD vector; untagged, reverse
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Supplemental Table 2: List of Primers Designed. Sequence from target vector – small letters        sequence change for mutagenesis – small 
letters, underlined
Primer Name Primer Sequence Use of primer
PW25Primer2 ACTGTGCGACAGAGTGAGAG In w+ gene in pw25 construct; reverse
PW25Primer3 GGTCGACTCTAGAGGATCAT In w+ gene in pw25 construct; forward
Primer Name Primer Sequence Use of primer
Sage 5' TCTCAACTACACCCTAACCGC TOPO Cloning, UAS-sage-GFP (5' Primer)
Sage 3' aacgatcattggggagcgtaa TOPO Cloning, UAS-sage-GFP (3' Primer)
Primer Name Primer Sequence Use of primer
CS00 cacc ATGAATCACCTATCGCCG TOPO Cloning, UAS-sens-GFP (5' Primer)
CS01 GCAGCTGCTGCTGCTCACCTCCATC TOPO Cloning, UAS-sens-GFP (3' Primer)
Primer Name Primer Sequence Use of primer
DJ060 GTCCTGGACTCGGCGGCGGCGGTCGcCAGCATGAGCGCCAGCATG Forward; Site directed mutagenesis of fkh (t->c; underlined)
DJ061 TTCAGAATAACCCCACCAGAATGTTGaCGCTCTCGGAGATCTATC Forward; Site directed mutagenesis of fkh (g->a; underlined)













































Supplemental Table 2: List of Primary Antibodies.
Primary Antibodies 
Antibody Species Use Concentration Source RRID 
Crb (CQ4) Mouse IHC 1:40 DSHB AB_528181  
CrebA Rabbit Polytene Chromosomes 1:5,000 Fox et al., 2010 AB_1085295 
CrebA Rabbit IHC 1:5,000 Fox et al., 2010 AB_1085295 
CrebA Rat Polytene Chromosomes   Andrew et al., 1997   
DCSP1 (ab49) Mouse IHC 1:100 DSHB AB_2307345   
en Rabbit IHC 1:100 Myat and Andrew, 2002   
GFP Mouse IHC 1:5,000 Molecular Probes   
GFP Mouse Western  1:5,000 Molecular Probes   
GFP Rabbit IHC 1:2,000 Life Technologies A11122 
GFP Rabbit IHC 1:10,000 Life Technologies A11122 
GM130 Rabbit IHC 1:100 Abcam   
Golgin245 Goat IHC 1:400 DSHB; Riedel et al 2016   
Rab11 Rabbit Western  1:5,000 Yim and Andrew (unpublished)   
Rab11 Rabbit IHC 1:500 Yim and Andrew (unpublished)   
Rab5 Guinea Pig Western  1:10,000 Tanaka and Nakamura, 2008   
Sage Rat IHC 1:1,000 Fox et al, 2013   
SG2 Rabbit IHC 1:8,000 Abrams et al., 2006   
Tbc1 Rat Western  1:1,000 This work   
Tbc1 Rat IHC 1:10 This work   
β-Gal Mouse IHC 1:100,000 Promega   
β-Gal Rabbit IHC 1:10,000 Promega   
βtub (AA4.3) Mouse Western/LICOR 1:1,000 DSHB AB_579793  
βtub (E7) Mouse Western/LICOR 1:500 DSHB AB_2315513  





Antibody Species Conjugate Concentration Source 
Goat Donkey 488 1:500 Invitrogen Molecular Probes 
Guinea Pig Goat 647 1:500 Invitrogen Molecular Probes 
Guinea Pig Goat 800CW 1:10,000 LI-COR 
Mouse Goat 488 1:500 Invitrogen Molecular Probes 
Mouse Goat 568 1:500 Invitrogen Molecular Probes 
Mouse Goat Biotin 1:500 Invitrogen Molecular Probes 
Mouse Goat HRP 1:10,000   
Rabbit Donkey 555 1:500 Invitrogen Molecular Probes 
Rabbit Donkey 568 1:500 Invitrogen Molecular Probes 
Rabbit Goat 488 1:500 Invitrogen Molecular Probes 
Rabbit Goat 568 1:500 Invitrogen Molecular Probes 
Rabbit Goat 800CW 1:10,000 LI-COR 
Rabbit Goat Biotin 1:500 Invitrogen Molecular Probes 
Rat Chicken 488 1:500   
Rat Donkey 647 1:500 Invitrogen Molecular Probes 
Rat Goat 555 1:500 Invitrogen Molecular Probes 
Rat Goat 647 1:500   
Rat Goat Biotin 1:500 Invitrogen Molecular Probes 
Rat Goat HRP 1:10,000   
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